{
  "meta": {
    "title": "00402_Late_Night_Pyq_Pyt_Pharma-3",
    "url": "https://brainandscalpel.vercel.app/00402-late-night-pyq-pyt-pharma-3-d43ae6e1.html",
    "scrapedAt": "2025-11-29T17:29:44.869Z"
  },
  "questions": [
    {
      "id": 33857,
      "choices": [
        {
          "id": 135266,
          "text": "<p><span style=\"font-size:12.0pt;\">Oral Labetalol</span></p>"
        },
        {
          "id": 135267,
          "text": "<p><span style=\"font-size:12.0pt;\">Intravenous labetalol</span></p>"
        },
        {
          "id": 135268,
          "text": "<p><span style=\"font-size:12.0pt;\">Nifedipine</span></p>"
        },
        {
          "id": 135269,
          "text": "<p><span style=\"font-size:12.0pt;\">Propranolol</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A pregnant female who is a known case of bronchial asthma presented to hospital with blood pressure of 160/100 mm Hg. Which of the following is the preferred drug for this patient?</span> <span style=\"font-size:12.0pt;\">(Fmge Jan 2024)</span></p>",
      "unique_key": "Q4242961",
      "question_audio": null,
      "question_video": null,
      "map_id": 32683649,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. C) Nifedipine</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Considering the patient's condition of bronchial asthma, beta-blockers like labetalol and propranolol may not be the best choices due to the risk of exacerbating asthma. Nicardipine, a calcium channel blocker, is a safer alternative in this scenario. It effectively lowers blood pressure and is safe to use in pregnancy, without the risk of bronchoconstriction.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option A.</strong> <strong>Oral Labetalol:</strong> Labetalol is a beta-blocker with alpha-blocking activity. It is commonly used for hypertension in pregnancy. However, being a beta-blocker, it can potentially exacerbate bronchial asthma by causing bronchoconstriction.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option B.</strong> <strong>Intravenous Labetalol:</strong> This would be used for more immediate control of severely elevated blood pressure, like in a hypertensive crisis. The same concerns regarding bronchial asthma apply as with oral labetalol.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option D.</strong> <strong>Propranolol:</strong> This is a non-selective beta-blocker and is generally contraindicated in asthma because it can cause bronchoconstriction. It is also not the first choice for managing hypertension in pregnancy.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Nifedipine, a calcium channel blocker is effective in lowering blood pressure and is generally considered safe in pregnancy. It does not have the bronchoconstrictive effects associated with beta-blockers.</span></p>",
      "correct_choice_id": 135268,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "FMGE",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 31853,
      "choices": [
        {
          "id": 127282,
          "text": "<p><span style=\"font-size:12.0pt;\">MAO inhibitors</span></p>"
        },
        {
          "id": 127283,
          "text": "<p><span style=\"font-size:12pt;\">Amitriptyline</span></p>"
        },
        {
          "id": 127284,
          "text": "<p><span style=\"font-size:12pt;\">Fluoxetine</span></p>"
        },
        {
          "id": 127285,
          "text": "<p><span style=\"font-size:12pt;\">Trazodone</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A patient on psychiatric medication developed a sudden hypertensive episode after consuming wine. Which of the following drugs is the person most likely taking? (Fmge July 2023)</span></p>",
      "unique_key": "Q9386962",
      "question_audio": null,
      "question_video": null,
      "map_id": 32683665,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. A) MAO inhibitors</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">MAO inhibitors are likely the cause of the hypertensive episode after consuming cheese or wine. This class of drugs can interact with tyramine, a substance found in cheese and wine, leading to a hypertensive crisis. This is known as cheese reaction.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option B. Amitriptyline:</strong> It is a tricyclic antidepressant. It doesn't cause hypertensive episodes in interaction with tyramine.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option C. Fluoxetine:</strong> A selective serotonin reuptake inhibitor (SSRI), fluoxetine is not known to cause hypertensive crises due to tyramine interaction.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option D. Trazodone:</strong> An antidepressant used for major depressive disorder and insomnia, trazodone is not associated with tyramine-induced hypertensive episodes.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">MAO inhibitors can cause hypertensive crises when patients consume foods high in tyramine, such as cheese and wine, due to the inhibition of tyramine breakdown, leading to its accumulation and subsequent hypertensive episodes.</span></p>",
      "correct_choice_id": 127282,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "Factual",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13066,
      "choices": [
        {
          "id": 52226,
          "text": "<p><span style=\"font-size:12.0pt;\">Beta blockers</span></p>"
        },
        {
          "id": 52227,
          "text": "<p><span style=\"font-size:12.0pt;\">Mannitol</span></p>"
        },
        {
          "id": 52228,
          "text": "<p><span style=\"font-size:12.0pt;\">Carbonic anhydrase inhibitors</span></p>"
        },
        {
          "id": 52229,
          "text": "<p><span style=\"font-size:12.0pt;\">Prostaglandin analogs</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 30-year-old female presents with redness and pain in the eye. Examination revealed an IOP of 38 mm of Hg, aqueous flare, and corneal precipitates. Which of the following drugs must be avoided in her? (INICET MAY 2021)</span></p>",
      "unique_key": "Q9648016",
      "question_audio": null,
      "question_video": null,
      "map_id": 32683627,
      "difficulty_level": "intermediate",
      "subjects_id": [
        8
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Prostaglandin analogs</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The clinical vignette suggests anterior uveitis with a raised intraocular pressure.</span></li><li><span style=\"font-size:12.0pt;\">Prostaglandin analogues like latanoprost increase uveoscleral outflow and lower intraocular pressure.</span></li><li><span style=\"font-size:12.0pt;\">Prostaglandin analogues act by stimulating prostanoid receptors on the ciliary muscles, leading to the release of matrix metalloproteinases that increase uveoscleral outflow.</span></li><li><span style=\"font-size:12.0pt;\">Prostaglandin analogues should be used with caution in patients with uveitis, iritis, cystoid macular edema, and herpes simplex keratitis.</span></li><li><span style=\"font-size:12.0pt;\">Prostaglandin analogues are the least suited for use in this patient as they can worsen the anterior uveitis.</span></li><li><span style=\"font-size:12.0pt;\">PG Analogues can also cause cystoids macular edema.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Beta blockers:</strong> These are generally safe in uveitis unless contraindicated for systemic reasons.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Mannitol:</strong> This osmotic diuretic can be used for quick reduction of IOP in acute settings but does not exacerbate uveitis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Carbonic anhydrase inhibitors:</strong> Also safe for use in reducing IOP in uveitis, unless systemic contraindications exist.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In patients with anterior uveitis and high IOP, prostaglandin analogs should be avoided due to their potential to worsen intraocular inflammation and the risk of inducing or exacerbating cystoid macular edema. Other options such as beta blockers, mannitol, and carbonic anhydrase inhibitors can be considered based on the individual patient's overall health and specific eye condition.</span></p>",
      "correct_choice_id": 52229,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20916,
      "choices": [
        {
          "id": 83628,
          "text": "<p><span style=\"font-size:12.0pt;\">The dose of telmisartan should be reduced in severe renal failure but not in hepatic failure</span></p>"
        },
        {
          "id": 83629,
          "text": "<p><span style=\"font-size:12.0pt;\">The dose of irbesartan should be reduced in case of severe hepatic failure and but not in renal failure</span></p>"
        },
        {
          "id": 83630,
          "text": "<p><span style=\"font-size:12.0pt;\">The dose of olmisartan should be reduced in severe liver failure as well as in renal failure</span></p>"
        },
        {
          "id": 83631,
          "text": "<p><span style=\"font-size:12.0pt;\">Losartan acts as thromboxane A2 antagonist and inhibits platelet aggregation</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The true statement among the following is: (NEET PG 2023)</span></p>",
      "unique_key": "Q8158310",
      "question_audio": null,
      "question_video": null,
      "map_id": 32683640,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Losartan acts as thromboxane A2 antagonist and inhibits platelet aggregation.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Losartan is an Angiotensin Receptor Blocker. It binds to the AT1 receptor with high affinity. It is also a competitive antagonist of the thromboxane A2 receptor and attenuates platelet aggregation. All ARBs are avoided in moderate to severe renal impairment due to risk of development of hyperkalemia. Most ARBs require dose adjustment in moderate to severe hepatic impairment also except LEO (Safe in <strong>L</strong>iver disease are <strong>E</strong>prosartan and <strong>O</strong>lmesartan)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option</strong></span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\"><strong>A. The dose of telmisartan should be reduced in severe renal failure but not in hepatic failure:</strong> Like all the ARBs, telmisartan is avoided in severe renal disease. Further, telmisartan is excreted by biliary secretion. So, dose of telmisartan should be reduced in mild to moderate hepatic failure.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. The dose of irbesartan should be reduced in case of severe hepatic failure and but not in renal failure:</strong> Irbesartan is avoided in both severe renal and hepatic disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C.</strong></span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\"><strong>The dose of olmisartan should be reduced in severe liver failure as well as in renal failure:</strong> Olmesartan require dose adjustment in severe renal failure. However, olmesartan and eprosartan do not require dose adjustment even in severe liver failure.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">All ARBs should be avoided in moderate to severe renal disease due to risk of hyperkalemia. Except Olmesartan and Eprosartan, all other ARBs require dose adjustment in moderate to severe hepatic disease also. Losartan has additional antiplatelet action by acting as TXA2 receptor antagonist.</span></p>",
      "correct_choice_id": 83631,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7089,
      "choices": [
        {
          "id": 28324,
          "text": "<p><span style=\"font-size:12.0pt;\">Aspirin</span></p>"
        },
        {
          "id": 28325,
          "text": "<p><span style=\"font-size:12.0pt;\">Paracetamol</span></p>"
        },
        {
          "id": 28326,
          "text": "<p><span style=\"font-size:12.0pt;\">Diclofenac</span></p>"
        },
        {
          "id": 28327,
          "text": "<p><span style=\"font-size:12.0pt;\">Ketorolac</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">NAPQI is the metabolite of which of the following drug toxicity? (</span><span style=\"background-color:rgb(255,255,255);color:rgb(111,126,149);font-size:14px;\">INICET May 2022)</span></p>",
      "unique_key": "Q2457550",
      "question_audio": null,
      "question_video": null,
      "map_id": 32683639,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B. Paracetamol</strong></span></p><p><br><span style=\"font-size:12.0pt;\">N-acetyl-p-benzoquinone imine (NAPQI) is a metabolite of paracetamol drug toxicity.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">NAPQI is highly reactive and has high affinity for sulfydryl groups. It causes enzymatic dysfunction in the liver. Normally, minor amounts of NAPQI produced in our body are rapidly eliminated by conjugation with reduced glutathione (GSH) that acts as a source of sulfhydryl group and then excreted into the urine.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Therefore, paracetamol toxicity is treated with N-acetyl cysteine (NAC), which provides the sulfhydryl group. NAC thereby helps in the excretion of NAPQI from the body.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The maximum recommended dose of acetaminophen is 4g/day.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Aspirin</strong>: Aspirin toxicity is not associated with NAPQI. Aspirin overdose primarily causes metabolic acidosis, respiratory alkalosis, and can lead to salicylate poisoning.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Diclofenac</strong>: Diclofenac toxicity does not involve NAPQI. Diclofenac is an NSAID that can cause gastrointestinal and renal toxicity.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Ketorolac</strong>: Ketorolac toxicity is not associated with NAPQI. Like other NSAIDs, ketorolac can cause gastrointestinal bleeding and renal toxicity.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">NAPQI is a toxic metabolite produced during the metabolism of paracetamol. In cases of paracetamol overdose, NAPQI accumulates and causes liver damage. The antidote for paracetamol toxicity is N-acetylcysteine (NAC), which helps detoxify NAPQI by replenishing glutathione and providing sulfhydryl groups.</span></p>",
      "correct_choice_id": 28325,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5502,
      "choices": [
        {
          "id": 21980,
          "text": "<p><span style=\"font-size:12.0pt;\">Gemfibrozil</span></p>"
        },
        {
          "id": 21981,
          "text": "<p><span style=\"font-size:12.0pt;\">Atorvastatin</span></p>"
        },
        {
          "id": 21982,
          "text": "<p><span style=\"font-size:12.0pt;\">Ezetimibe</span></p>"
        },
        {
          "id": 21983,
          "text": "<p><span style=\"font-size:12.0pt;\">Niacin</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Which of the following anti-dyslipidemic drug work by stimulating Peroxisome proliferator activated receptor (PPAR) alpha? (Fmge Jan 2023)</span></p>",
      "unique_key": "Q8868666",
      "question_audio": null,
      "question_video": null,
      "map_id": 32683679,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Ans. A. Gemfibrozil</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><ul><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Fibrates are a class of hypolipidemic drugs.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">They include Gemfibrozil, Fenofibrate, Clofibrate.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">They are mainly used in Hypertriglyceridemia and chylomicronemia syndromes.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Fibrates bind to the PPAR alpha and stimulates Lipoprotein lipase thus enhancing the clearance of VLDL.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Their important side effects include: Gallstones formation and Myopathy.</span></p></li></ul><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option B. Atorvastatin:</strong> Atorvastatin is a statin, which is an HMG-CoA reductase inhibitor. It works by inhibiting the enzyme HMG-CoA reductase, a key enzyme in the biosynthesis of cholesterol in the liver, leading to reduced levels of LDL cholesterol.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option C. Ezetimibe:</strong> Ezetimibe decreases the absorption of cholesterol from the small intestine. It targets and inhibits the Niemann-Pick C1-Like 1 (NPC1L1) protein, which is involved in the uptake of cholesterol.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option D. Niacin:</strong> Niacin, also known as vitamin B3, works by decreasing hormone-sensitive lipase activity, which leads to reduced breakdown of fats in adipose tissue. This decreases the levels of free fatty acids available for hepatic triglyceride synthesis, leading to lower levels of LDL and VLDL and an increase in HDL.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Fibrates, including gemfibrozil, work by stimulating PPAR-α, which enhances the activity of lipoprotein lipase, leading to increased clearance of VLDL and triglycerides. This mechanism makes fibrates particularly effective in treating hypertriglyceridemia and related disorders. Other hypolipidemic drugs like atorvastatin, ezetimibe, and niacin have different mechanisms of action targeting other aspects of lipid metabolism.</span></p>",
      "correct_choice_id": 21980,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6906,
      "choices": [
        {
          "id": 27592,
          "text": "<p><span style=\"font-size:12.0pt;\">Endometriosis</span></p>"
        },
        {
          "id": 27593,
          "text": "<p><span style=\"font-size:12.0pt;\">Male infertility</span></p>"
        },
        {
          "id": 27594,
          "text": "<p><span style=\"font-size:12.0pt;\">Central precocious puberty</span></p>"
        },
        {
          "id": 27595,
          "text": "<p><span style=\"font-size:12.0pt;\">Prostate cancer</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"color:#333333;font-size:12pt;\">Non-pulsatile dose of GnRH agonist is used in all of the following conditions except? (AIIMS NOV 2019)</span></p>",
      "unique_key": "Q7178981",
      "question_audio": null,
      "question_video": null,
      "map_id": 32683675,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"color:#333333;font-size:12pt;\"><strong>Ans. B. Male infertility</strong></span></p><p>&nbsp;</p><p><span style=\"color:#333333;font-size:12pt;\">Pulsatile exposure to GnRH induces FSH/LH secretion while sustained exposure de-sensitizes the receptors resulting in decrease in secretion of gonadotropins. Therefore, non-pulsatile (continuous) GnRH agonists are given when we want to decrease the sex hormones.</span></p><p>&nbsp;</p><p><span style=\"color:#333333;font-size:12pt;\"><strong>Indications:-</strong></span></p><p>&nbsp;</p><ul><li><span style=\"color:#333333;font-size:12pt;\">&nbsp;Prostatic carcinoma</span></li><li><span style=\"color:#333333;font-size:12pt;\">&nbsp;Endometriosis</span></li><li><span style=\"color:#333333;font-size:12pt;\">&nbsp;Precocious puberty</span></li><li><span style=\"color:#333333;font-size:12pt;\">&nbsp;Fibroid</span></li></ul><p>&nbsp;</p><p><span style=\"color:#333333;font-size:12pt;\">But in case of male infertility, more testosterone is required to induce spermatogenesis, so GnRH agonists are given in pulsatile manner.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Endometriosis:&nbsp;</strong>In endometriosis, continuous GnRH agonists are used to lower estrogen levels, which helps reduce the growth of endometrial tissue and alleviate symptoms.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Central precocious puberty</strong></span><span style=\"font-size:12pt;\"><strong>:</strong></span><span style=\"font-size:14px;\"><strong>&nbsp;</strong></span><span style=\"font-size:12pt;\">Continuous GnRH agonists are used to decrease sex hormone levels, thereby delaying early onset puberty.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Prostate cancer:&nbsp;</strong>Continuous GnRH agonists reduce testosterone levels, which helps in managing prostate cancer by slowing down the growth of cancer cells.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Non-pulsatile (continuous) GnRH agonists are used to decrease sex hormone levels in conditions such as endometriosis, central precocious puberty, and prostate cancer. In male infertility, pulsatile GnRH agonists are used to increase testosterone and induce spermatogenesis.</span></p><p>&nbsp;</p><p><span style=\"color:#333333;font-size:12pt;\"><strong>Reference: KDT 8th/. 262,263</strong></span></p>",
      "correct_choice_id": 27593,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7037,
      "choices": [
        {
          "id": 28116,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Erection</span></span></span></span></p>"
        },
        {
          "id": 28117,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ejaculation </span></span></span></span></p>"
        },
        {
          "id": 28118,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Dilation of bronchus </span></span></span></span></p>"
        },
        {
          "id": 28119,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Increased cardiac contractility</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Muscarinic receptor stimulation primarily causes which of the following actions?<strong> </strong></span></span></p>",
      "unique_key": "Q1394081",
      "question_audio": null,
      "question_video": null,
      "map_id": 32683655,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A. Erection</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Parasympathetic (muscarinic) stimulation result in erection whereas sympathetic stimulation causes ejaculation.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Parasympathetic system causes bronchoconstriction whereas sympathetic system result in bronchodilation.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increase in cardiac contractility is primarily action of beta 1 receptors of the heart.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mnemonic</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Point and Shoot: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/18/screenshot-2024-07-18-100906.png\" style=\"height:163px; width:1000px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B.</span></strong> <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ejaculation:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ejaculation is primarily mediated by the sympathetic nervous system, not the parasympathetic system. Thus, muscarinic receptor stimulation does not cause ejaculation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Dilation of bronchus</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: The parasympathetic system causes bronchoconstriction. Bronchodilation is mediated by the sympathetic nervous system.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Increased cardiac contractility:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increased cardiac contractility is primarily an action of beta-1 adrenergic receptors, which are part of the sympathetic nervous system. Muscarinic receptor stimulation generally results in decreased heart rate and contractility.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Muscarinic receptor stimulation is associated with parasympathetic responses such as erection, while sympathetic stimulation is responsible for ejaculation, bronchodilation, and increased cardiac contractility.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>",
      "correct_choice_id": 28116,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4255,
      "choices": [
        {
          "id": 16997,
          "text": "<p><span style=\"font-size:12.0pt;\">Crista ampullaris</span></p>"
        },
        {
          "id": 16998,
          "text": "<p><span style=\"font-size:12.0pt;\">Macula</span></p>"
        },
        {
          "id": 16999,
          "text": "<p><span style=\"font-size:12.0pt;\">Cupola</span></p>"
        },
        {
          "id": 17000,
          "text": "<p><span style=\"font-size:12.0pt;\">Outer hair cells</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A metal factory worker suffers from noise-induced hearing loss. Which of the following structures will be affected? (AIIMS NOV 2017)</span></p>",
      "unique_key": "Q7513863",
      "question_audio": null,
      "question_video": null,
      "map_id": 32683632,
      "difficulty_level": "beginner",
      "subjects_id": [
        9
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Outer hair cells</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Noise-Induced Hearing Loss (NIHL) causes damage to outer hair cells.</span></li><li><span style=\"font-size:12.0pt;\">NIHL Hearing loss, in this case, is due to chronic exposure.</span></li><li><span style=\"font-size:12.0pt;\">It can be of two types</span><br>&nbsp;<ol style=\"list-style-type:decimal;\"><li><span style=\"font-size:12.0pt;\">Temporary threshold shift (TTS). The hearing is impaired immediately after exposure to noise but recovers after an interval of a few minutes to a few hours even up to 2 weeks</span></li><li><span style=\"font-size:12.0pt;\">Permanent threshold shift (PTS). The hearing impairment is permanent and does not recover at all.</span></li></ol></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The audiogram in NIHL shows a typical notch, at 4 kHz, both for air and bone conduction. This is referred to as acoustic dip or Boiler's notch.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/29/picture14.jpg\" alt=\"\" width=\"500\" height=\"405\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The damage caused by noise trauma depends on several factors:</span></p><p>&nbsp;</p><ol style=\"list-style-type:upper-roman;\"><li><span style=\"font-size:12.0pt;\">Frequency of noise. A frequency of 2000–3000 Hz causes more damage than lower or higher frequencies.</span></li><li><span style=\"font-size:12.0pt;\">Intensity and duration of noise. As the intensity increases, permissible time for exposure is reduced.</span></li><li><span style=\"font-size:12.0pt;\">Continuous noise is more harmful.</span></li><li><span style=\"font-size:12.0pt;\">Susceptibility of the individual. Degree of TTS and PTS varies in different individuals.</span></li><li><span style=\"font-size:12.0pt;\">Pre-existing ear disease.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Crista ampullaris:</strong> This structure is located within the semicircular canals of the inner ear and is primarily involved in sensing rotational movements of the head, not in hearing. Thus, it is not typically affected by noise-induced hearing loss.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Macula:</strong> Found in the utricle and saccule of the vestibular system, the macula detects linear accelerations and head tilts but is not directly involved in the auditory response to sound waves.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Cupola:</strong> The cupola is a gelatin-like structure in the vestibular system's semicircular canals that responds to changes in head position. Like the crista ampullaris, it is unrelated to the hearing process.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Noise-induced hearing loss specifically damages the outer hair cells in the cochlea, leading to hearing impairment.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref - Dhingra 7<sup>th</sup> edition, Page No. 36, 37</strong></span></p>",
      "correct_choice_id": 17000,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6529,
      "choices": [
        {
          "id": 26085,
          "text": "<p><span style=\"font-size:12.0pt;\">Octreotide</span></p>"
        },
        {
          "id": 26086,
          "text": "<p><span style=\"font-size:12.0pt;\">Pegvisomant</span></p>"
        },
        {
          "id": 26087,
          "text": "<p><span style=\"font-size:12.0pt;\">Cabergoline</span></p>"
        },
        {
          "id": 26088,
          "text": "<p><span style=\"font-size:12.0pt;\">Olcegepant</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A middle-aged male patient presents with chin protrusion, excessive sweating, impaired glucose tolerance, and hand and foot enlargement. What is a growth hormone receptor antagonist used to treat this condition?</span> <span style=\"font-size:12.0pt;\">(NEET PG 2022)</span></p>",
      "unique_key": "Q1518613",
      "question_audio": null,
      "question_video": null,
      "map_id": 32683620,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Pegvisomant</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The patient's symptoms suggest acromegaly, a condition characterized by excessive growth hormone (GH) secretion, usually due to a pituitary adenoma. Pegvisomant is a growth hormone receptor antagonist used in the treatment of acromegaly. It blocks the effects of growth hormone at the receptor level, leading to decreased levels of insulin-like growth factor-1 (IGF-1), which is responsible for the acromegaly symptoms.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Octreotide</strong>: Octreotide is a somatostatin analogue, which can be used in the treatment of acromegaly. It works by inhibiting the release of growth hormone from the pituitary gland. However, it is not a growth hormone receptor antagonist; instead, it reduces GH secretion.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Cabergoline</strong>: Cabergoline is a dopamine agonist primarily used in the treatment of prolactinomas, another type of pituitary adenoma. It is not typically used as a first-line treatment for acromegaly and does not act as a growth hormone receptor antagonist.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Olcegepant</strong>: Olcegepant is a calcitonin gene-related peptide receptor antagonist used in the research for migraine treatment. It is not used in the treatment of acromegaly or related to growth hormone activity.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Pegvisomant is a growth hormone receptor antagonist used to treat acromegaly by blocking the effects of growth hormone at the receptor level, thereby reducing the symptoms associated with elevated growth hormone levels.</span></p>",
      "correct_choice_id": 26086,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 31859,
      "choices": [
        {
          "id": 127306,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Metronidazole </span></span></p>"
        },
        {
          "id": 127307,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tinidazole </span></span></p>"
        },
        {
          "id": 127308,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Erythromycin </span></span></p>"
        },
        {
          "id": 127309,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Clindamycin</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following drugs is not used in the treatment of bacterial vaginosis? (Fmge July 2023)</span></span></p>",
      "unique_key": "Q2819493",
      "question_audio": null,
      "question_video": null,
      "map_id": 32683669,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. C) Erythromycin</strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Erythromycin is not typically used in the treatment of bacterial vaginosis. It is an antibiotic more commonly used for respiratory infections and certain skin infections.</span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Other Options:</strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A. Metronidazole:</strong> This is drug of choice for treating bacterial vaginosis.</span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B. Tinidazole:</strong> Similar to metronidazole, tinidazole is also effective against bacterial vaginosis.</span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D. Clindamycin:</strong> Clindamycin is another antibiotic that can be used to treat bacterial vaginosis.</span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Educational Objective: </strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Erythromycin is not typically used for bacterial vaginosis, whereas metronidazole, tinidazole, and clindamycin are effective treatments for this condition due to their efficacy against anaerobic bacteria.</span></span></p>",
      "correct_choice_id": 127308,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "FMGE",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6525,
      "choices": [
        {
          "id": 26069,
          "text": "<p><span style=\"font-size:12.0pt;\">DNA gyrase inhibition</span></p>"
        },
        {
          "id": 26070,
          "text": "<p><span style=\"font-size:12.0pt;\">Ribosomal inhibition</span></p>"
        },
        {
          "id": 26071,
          "text": "<p><span style=\"font-size:12.0pt;\">Cell wall synthesis inhibition</span></p>"
        },
        {
          "id": 26072,
          "text": "<p><span style=\"font-size:12.0pt;\">Inhibition of folic acid synthesis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A woman presenting with symptoms of urinary tract infection was prescribed a drug that causes tendon rupture and arthropathy. What is the mechanism of action of the drug? (NEET PG 2022)</span></p>",
      "unique_key": "Q4043804",
      "question_audio": null,
      "question_video": null,
      "map_id": 32683678,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) DNA gyrase inhibition</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The description of a drug causing tendon rupture and arthropathy, especially in the context of treating a urinary tract infection, points towards a fluoroquinolone antibiotic. Fluoroquinolones, such as ciprofloxacin, work by inhibiting bacterial DNA gyrase and topoisomerase IV, which are essential for bacterial DNA replication and transcription.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Ribosomal Inhibition:</strong> Antibiotics that inhibit ribosomes, such as macrolides, tetracyclines, and aminoglycosides, affect protein synthesis. These drugs are not typically associated with tendon rupture or arthropathy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Cell Wall Synthesis Inhibition</strong>: Drugs that inhibit cell wall synthesis, like beta-lactams (penicillins, cephalosporins) and vancomycin, are not known to cause tendon rupture or arthropathy as a common side effect.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Inhibition of Folic Acid Synthesis</strong>: Antibiotics that inhibit folic acid synthesis, such as sulfonamides and trimethoprim, do not typically cause tendon rupture or arthropathy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Fluoroquinolones, which inhibit DNA gyrase and topoisomerase IV, are associated with serious side effects such as tendon rupture and arthropathy.</span></p>",
      "correct_choice_id": 26069,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5499,
      "choices": [
        {
          "id": 21968,
          "text": "<p><span style=\"font-size:12.0pt;\">It acts as a calcium chelator and reduces the availability of calcium in coagulation pathway</span></p>"
        },
        {
          "id": 21969,
          "text": "<p><span style=\"font-size:12.0pt;\">It binds and activates anti-thrombin 3 that accelerates its interaction with thrombin and factor Xa resulting in their degradation</span></p>"
        },
        {
          "id": 21970,
          "text": "<p><span style=\"font-size:12.0pt;\">It acts as a Vitamin K inhibitor that leads to inhibition of activation of clotting factors 2,7,9 and 10</span></p>"
        },
        {
          "id": 21971,
          "text": "<p><span style=\"font-size:12.0pt;\">It inhibits tissue plasminogen activator resulting in stoppage of conversion of plasminogen to plasmin</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Which of the following statements is most appropriate regarding mechanism of action of dicumarol? (Fmge Jan 2023)</span></p>",
      "unique_key": "Q8075451",
      "question_audio": null,
      "question_video": null,
      "map_id": 32683676,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Ans. C. It acts as a Vitamin K inhibitor that leads to inhibition of activation of clotting factors 2,7,9 and 10</strong></span><br>&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">The mechanism of action of dicumarol is similar to that of Warfarin. It acts by inhibiting the enzyme - Vitamin K Epoxide Reductase (VKOR), which is necessary for activation of the clotting factors 2, 7, 9 and 10 by Gamma Carboxylation of their glutamate residues.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option A. It acts as a calcium chelator and reduces the availability of calcium in the coagulation pathway:</strong> This describes the mechanism of action of EDTA (ethylenediaminetetraacetic acid), which is used in laboratory settings to prevent blood clotting by chelating calcium, a necessary cofactor in the coagulation cascade.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option B. It binds and activates anti-thrombin 3 that accelerates its interaction with thrombin and factor Xa resulting in their degradation:</strong> This describes the mechanism of action of heparin. Heparin enhances the activity of antithrombin III, leading to the inactivation of thrombin and factor Xa, thus preventing clot formation.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option D. It inhibits tissue plasminogen activator resulting in stoppage of conversion of plasminogen to plasmin:</strong> This describes the mechanism of action of antifibrinolytic agents such as tranexamic acid or epsilon-aminocaproic acid (EACA), which inhibit tissue plasminogen activator (tPA) and prevent the conversion of plasminogen to plasmin, thereby inhibiting fibrinolysis and stabilizing clots.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Dicumarol acts as a Vitamin K inhibitor, preventing the activation of clotting factors II, VII, IX, and X by inhibiting the enzyme Vitamin K Epoxide Reductase (VKOR). This inhibition is crucial for its anticoagulant effect, similar to that of warfarin.</span></p>",
      "correct_choice_id": 21970,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 57288,
      "choices": [
        {
          "id": 228533,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dhatura poisoning</span></span></p>"
        },
        {
          "id": 228534,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Alcohol intoxication</span></span></p>"
        },
        {
          "id": 228535,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Opioid overdose</span></span></p>"
        },
        {
          "id": 228536,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cocaine poisoning</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient is found on a railway track with hot dry skin, raised temperature, dilated pupils, slurred speech, and a staggering gait. Which of the following is the most likely cause? (NEET PG 2024)</span></span></span></p>",
      "unique_key": "Q6946811",
      "question_audio": null,
      "question_video": null,
      "map_id": 32683652,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Dhatura poisoning</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The patient presents with several characteristic signs and symptoms: hot dry skin, raised temperature (hyperthermia), dilated pupils (mydriasis), slurred speech, and staggering gait. These symptoms are indicative of anticholinergic poisoning, and specifically point towards <strong>Dhatura poisoning</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dhatura (Datura) is a plant that contains tropane alkaloids, such as atropine, scopolamine, and hyoscyamine, which have strong anticholinergic effects. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">These effects include: <strong>(Mnemonic DHATURA)</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dryness</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> of skin and mucous membranes (due to inhibition of sweat and salivary glands).</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hyperthermia</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> (elevated body temperature) because of decreased sweating.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mydriasis</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> (Dilated pupils), leading to photophobia and blurred vision.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Agitation</span></strong></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tachycardia</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Urinary Retention</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> and loss of accommodation (difficulty focusing).</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">ccommodation loss &ndash; Blurred Vision </span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Slurred speech</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> and <strong>staggering gait</strong> can also be observed due to central nervous system effects.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Alcohol intoxication</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: While slurred speech and a staggering gait are common in alcohol intoxication, alcohol typically causes <strong>hypothermia</strong> (lowered body temperature), not hyperthermia. Also, alcohol intoxication generally does not cause hot, dry skin or dilated pupils.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Opioid overdose</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This usually presents with pinpoint pupils (miosis), respiratory depression, and unconsciousness, not dilated pupils, hyperthermia, or dry skin.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Cocaine poisoning</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Cocaine can cause hyperthermia and dilated pupils, but it typically results in increased activity and agitation rather than the slurred speech and staggering gait associated with Dhatura poisoning. Additionally, the dry skin is more characteristic of anticholinergic toxicity.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dhatura poisoning</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> is characterized by anticholinergic symptoms such as hot dry skin, hyperthermia, dilated pupils, slurred speech, and a staggering gait, distinguishing it from other causes of altered mental status.</span></span></span></p>",
      "correct_choice_id": 228533,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6524,
      "choices": [
        {
          "id": 26065,
          "text": "<p><span style=\"font-size:12.0pt;\">Vitamin E</span></p>"
        },
        {
          "id": 26066,
          "text": "<p><span style=\"font-size:12.0pt;\">Vitamin K</span></p>"
        },
        {
          "id": 26067,
          "text": "<p><span style=\"font-size:12.0pt;\">Vitamin B6</span></p>"
        },
        {
          "id": 26068,
          "text": "<p><span style=\"font-size:12.0pt;\">Vitamin D</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A young patient began taking a weight loss medication that works by preventing fat absorption from food. She developed easy bruising and increased menstrual bleeding after a few weeks. Which of the following vitamins deficiency is likely to be responsible for her condition? (NEET PG 2022)</span></p>",
      "unique_key": "Q7651343",
      "question_audio": null,
      "question_video": null,
      "map_id": 32683677,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Vitamin K</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Vitamin A, D, E and K are fat soluble vitamins. Their absorption is hampered when the absorption of fat is prevented by a medication (eg Orlistat , Ezetimibe etc).</span></li><li><span style=\"font-size:12.0pt;\">Vitamin K is required for the Gamma carboxylation of Glutamic acid residues of clotting factors 2 ,7 ,9 and 10 in order to activate them. If Vitamin K is deficient due to fat malabsorption, as in the above case, then there can be bleeding manifestations in the form of easy bruising and increased menstrual bleeding in females. The Prothrombin Time (PT) will be elevated.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Vitamin E:&nbsp;</strong>Vitamin E deficiency can manifest as hemolytic anemia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Vitamin B6:&nbsp;</strong>Vitamin B6 deficiency can be seen with drugs like Isoniazid, Penicillamine, Hydralazine, OCP. Patients can have peripheral neuritis, lowered seizure threshold, or convulsions.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Vitamin D:</strong> Vitamin D deficiency leads to the development of rickets in children and osteomalacia in adults.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Vitamin K deficiency due to impaired fat absorption from weight loss medications can lead to bleeding manifestations such as easy bruising and increased menstrual bleeding.</span></p>",
      "correct_choice_id": 26066,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6486,
      "choices": [
        {
          "id": 25913,
          "text": "<p><span style=\"font-size:12.0pt;\">Trihexyphenidyl</span></p>"
        },
        {
          "id": 25914,
          "text": "<p><span style=\"font-size:12.0pt;\">Entacapone</span></p>"
        },
        {
          "id": 25915,
          "text": "<p><span style=\"font-size:12.0pt;\">Rasagiline</span></p>"
        },
        {
          "id": 25916,
          "text": "<p><span style=\"font-size:12.0pt;\">Pramipexole</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 36-year-old male with a diagnosis of schizophrenia was started on an antipsychotic medication. Within a few weeks, he developed symptoms of Parkinsonism, such as bradykinesia, rigidity, and a shuffling gait. The medical team is considering prescribing an additional medication to manage these extrapyramidal side effects. Which of the following drugs can be given to this patient? (NEET PG 2020)</span></p>",
      "unique_key": "Q8021983",
      "question_audio": null,
      "question_video": null,
      "map_id": 32683659,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Trihexyphenidyl</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Trihexyphenidyl is an anticholinergic medication commonly used to treat extrapyramidal symptoms like Parkinsonism that may arise as a side effect of antipsychotic medications. It can counteract the dopamine antagonism caused by antipsychotic drugs, thereby alleviating symptoms such as tremors, rigidity, and bradykinesia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Entacapone:</strong> Entacapone is a COMT inhibitor used in the treatment of Parkinson's disease to prolong the action of levodopa. It's not typically used to treat drug-induced Parkinsonism.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Rasagiline:</strong> Rasagiline is a monoamine oxidase type B (MAO-B) inhibitor used primarily in Parkinson's disease. It's not commonly used for drug-induced extrapyramidal symptoms.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Pramipexole:</strong> Pramipexole is a dopamine agonist also used in the treatment of Parkinson's disease but is ineffective in treatment of extrapyramidal symptoms induced by antipsychotic medications.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Trihexyphenidyl is the appropriate medication for managing extrapyramidal side effects, such as Parkinsonism, induced by antipsychotic medications. It works by counteracting the dopamine antagonism and restoring the balance between acetylcholine and dopamine in the brain.</span></p>",
      "correct_choice_id": 25913,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6487,
      "choices": [
        {
          "id": 25917,
          "text": "<p><span style=\"font-size:12.0pt;\">Amiodarone</span></p>"
        },
        {
          "id": 25918,
          "text": "<p><span style=\"font-size:12.0pt;\">Sotalol</span></p>"
        },
        {
          "id": 25919,
          "text": "<p><span style=\"font-size:12.0pt;\">Quinidine</span></p>"
        },
        {
          "id": 25920,
          "text": "<p><span style=\"font-size:12.0pt;\">Lignocaine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following antiarrhythmic drugs is contraindicated in a patient with interstitial lung disease? (NEET PG 2020)</span></p>",
      "unique_key": "Q7671764",
      "question_audio": null,
      "question_video": null,
      "map_id": 32683660,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Amiodarone</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Amiodarone is a class III anti arrhythmic drug. One of the adverse effects of amiodarone that is seen with long term therapy is pulmonary fibrosis, which can be rapidly progressive. Therefore, it is contraindicated in patients with interstitial lung disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The other adverse effects include hepatotoxicity, hypothyroidism or hyperthyroidism (Amiodarone is 40% iodine by weight), blue grey skin pigmentation, corneal deposits, constipation and bradycardia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Sotalol</strong>: Sotalol is also a class III antiarrhythmic agent but does not have the same risk of pulmonary toxicity as amiodarone. It is generally considered safer for patients with interstitial lung disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Quinidine</strong>: Quinidine is a class I antiarrhythmic drug that is not associated with pulmonary toxicity. It has other potential side effects but is not contraindicated in interstitial lung disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Lignocaine</strong>: Lignocaine (lidocaine) is a class Ib antiarrhythmic agent primarily used for ventricular arrhythmias. It does not have pulmonary toxicity and is not contraindicated in patients with interstitial lung disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Amiodarone is contraindicated in patients with interstitial lung disease due to its potential to cause pulmonary fibrosis, a serious and potentially irreversible adverse effect. It is essential to consider this risk when prescribing antiarrhythmic therapy to patients with pre-existing lung conditions.</span></p>",
      "correct_choice_id": 25917,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7027,
      "choices": [
        {
          "id": 28076,
          "text": "<p><span style=\"color:#333333;font-size:12pt;\">Chlorthalidone</span></p>"
        },
        {
          "id": 28077,
          "text": "<p><span style=\"color:#333333;font-size:12pt;\">Triamterene</span></p>"
        },
        {
          "id": 28078,
          "text": "<p><span style=\"color:#333333;font-size:12pt;\">Spironolactone</span></p>"
        },
        {
          "id": 28079,
          "text": "<p><span style=\"color:#333333;font-size:12pt;\">Furosemide</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"color:#333333;font-size:12.0pt;\">Preferred&nbsp;drug for the treatment of a 48-year-old man with uncomplicated grade 2 hypertension without any associated co-morbidity is (AIIMS MAY 2019)</span></p>",
      "unique_key": "Q9954479",
      "question_audio": null,
      "question_video": null,
      "map_id": 32683671,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"color:#333333;font-size:12pt;\"><strong>Ans.&nbsp;A. Chlorthalidone</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Chlorthalidone</strong> is a thiazide-like diuretic that is highly effective in lowering blood pressure and is often recommended as the preferred first-line treatment for uncomplicated grade 2 hypertension. It has a longer duration of action compared to other thiazides, such as hydrochlorothiazide, making it particularly effective in managing hypertension over a 24-hour period.</span></li><li><span style=\"color:#333333;font-size:12pt;\">According to ACC Guidelines and JNC 8 Guidelines, the DOC for hypertension is Thiazides (preferred diuretic).</span></li><li><span style=\"color:#333333;font-size:12pt;\">Apart from thiazides, the other first line drugs for hypertension are-</span></li><li><span style=\"color:#333333;font-size:12pt;\">ACE Inhibitors</span></li><li><span style=\"color:#333333;font-size:12pt;\">Angiotensin receptor blockers</span></li><li><span style=\"color:#333333;font-size:12pt;\">Calcium channel blockers</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Triamterene</strong>: This is a potassium-sparing diuretic. It is primarily used in combination with other diuretics to prevent hypokalemia but is not recommended as a first-line treatment for hypertension.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Spironolactone</strong>: Another potassium-sparing diuretic, primarily used in conditions such as heart failure, hyperaldosteronism, and resistant hypertension, not as a first-line treatment for uncomplicated hypertension.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Furosemide</strong>: This is a loop diuretic, which is typically used in conditions such as congestive heart failure, renal insufficiency, and edema. It is not recommended as a first-line treatment for uncomplicated hypertension due to its short duration of action and the potential for significant electrolyte disturbances.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">For the treatment of uncomplicated grade 2 hypertension without any associated comorbidities, thiazide diuretics, particularly chlorthalidone, are the preferred first-line agents according to ACC and JNC 8 guidelines.</span></p><p>&nbsp;</p><p><span style=\"color:#333333;font-size:12pt;\"><strong>Reference: - KDT 8<sup>TH</sup>/615</strong></span></p>",
      "correct_choice_id": 28076,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6461,
      "choices": [
        {
          "id": 25813,
          "text": "<p><span style=\"font-size:12.0pt;\">Timolol</span></p>"
        },
        {
          "id": 25814,
          "text": "<p><span style=\"font-size:12.0pt;\">Brimonidine</span></p>"
        },
        {
          "id": 25815,
          "text": "<p><span style=\"font-size:12.0pt;\">Latanoprost</span></p>"
        },
        {
          "id": 25816,
          "text": "<p><span style=\"font-size:12.0pt;\">Dorzolamide</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A pediatric patient is brought to the emergency department with signs of ocular hypotension and apnea. The parents are concerned about the child's condition and have provided a history of recent medication use. It is crucial to determine which drug may have caused these symptoms in the infant. Drug capable of causing ocular hypotension with apnea in infants is:</span><span style=\"font-size:10.5pt;\"> </span><span style=\"font-size:12.0pt;\">(NEET PG 2019)</span></p>",
      "unique_key": "Q2462319",
      "question_audio": null,
      "question_video": null,
      "map_id": 32683645,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Brimonidine</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Brimonidine is an alpha-2 adrenergic agonist used to lower intraocular pressure in conditions such as glaucoma. It acts by decreasing the production of aqueous humor and increasing its outflow, thereby reducing intraocular pressure. While brimonidine is generally well-tolerated, it can have systemic side effects, particularly in infants. The most concerning systemic side effect in this context is central nervous system depression, which can manifest as symptoms like apnea (temporary cessation of breathing). Infants, especially premature ones, are more susceptible to such side effects. Therefore, brimonidine is the drug most likely responsible for causing ocular hypotension with apnea in this case.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Timolol:</strong> Timolol is a beta-blocker commonly used to lower intraocular pressure. While it can have systemic side effects, including bradycardia and bronchospasm, it is not typically associated with apnea in infants.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Latanoprost:</strong> Latanoprost is a prostaglandin analog that lowers intraocular pressure by increasing the outflow of aqueous humor. It can cause side effects such as changes in iris color and eyelash growth. However, it is not known to cause apnea in infants.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Dorzolamide:</strong> Dorzolamide is a carbonic anhydrase inhibitor used in ophthalmology to reduce intraocular pressure. While it can cause ocular hypotension, it is not a common cause of apnea, especially in infants.</span></p>",
      "correct_choice_id": 25814,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "OlderNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 51447,
      "choices": [
        {
          "id": 205309,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Metformin</span></p>"
        },
        {
          "id": 205310,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Glimepiride</span></p>"
        },
        {
          "id": 205311,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Sitagliptin</span></p>"
        },
        {
          "id": 205312,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Pioglitazone</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A man with diabetes was on medication and forgot to take his meals before going to the gym. During his workout, he collapsed, and his blood sugar level was found to be 50 mg/dL. Which of the following oral antidiabetic drugs can result in hypoglycemia when used as monotherapy? (FMGE JULY 2024)</span></p>",
      "unique_key": "Q8850599",
      "question_audio": null,
      "question_video": null,
      "map_id": 32683673,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Ans. B) Glimepiride</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Glimepiride is a sulfonylurea, a class of oral antidiabetic drugs known to stimulate insulin release from pancreatic beta cells. This action can lead to a decrease in blood glucose levels, which, if not balanced with adequate food intake, can result in hypoglycemia. The patient's low blood sugar level (50 mg/dL) and the scenario of collapsing during a workout indicate that hypoglycemia occurred, likely due to the effect of glimepiride.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>[Mnemonic: any drug which ends with “ide” can cause hypoglycemia, except glutides (liraglutide), axenatide]</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option A. Metformin</strong>: Metformin is a biguanide that primarily decreases hepatic glucose production and increases insulin sensitivity. It does not usually cause hypoglycemia when used as monotherapy because it does not stimulate insulin secretion.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option C. Sitagliptin</strong>: Sitagliptin is a DPP-4 inhibitor that increases incretin levels, which in turn increases insulin release and decreases glucagon levels. However, it does not generally cause hypoglycemia as monotherapy because its action is glucose-dependent.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option D. Pioglitazone</strong>: Pioglitazone is a thiazolidinedione that increases insulin sensitivity but does not stimulate insulin release. Thus, it does not typically cause hypoglycemia when used alone.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Sulfonylureas, like glimepiride, can cause hypoglycemia, especially when meals are skipped, due to their insulin-stimulating effects.</span></p>",
      "correct_choice_id": 205310,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "FMGE",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 24713,
      "choices": [
        {
          "id": 98813,
          "text": "<p><span style=\"font-size:12.0pt;\">Inhibition of angiogenesis</span></p>"
        },
        {
          "id": 98814,
          "text": "<p><span style=\"font-size:12.0pt;\">Increase in IL-2, IL-4 and IL-5</span></p>"
        },
        {
          "id": 98815,
          "text": "<p><span style=\"font-size:12.0pt;\">Generation of oxygen free radicals</span></p>"
        },
        {
          "id": 98816,
          "text": "<p><span style=\"font-size:12.0pt;\">Binding to cereblon</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Mechanism of thalidomide teratogenicity include all except</span></p>",
      "unique_key": "Q1834330",
      "question_audio": null,
      "question_video": null,
      "map_id": 32683626,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B. Increase in IL-2, IL-4 and IL-5</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Thalidomide actually suppresses the production of certain cytokines, including IL-2, IL-4, and IL-5. The suppression of these interleukins is part of its immunomodulatory effects, not a mechanism of teratogenicity. Thalidomide suppresses the production of interleukins which is an important mechanism in treatment of multiple myeloma.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The exact mechanism of thalidomide's teratogenicity is not completely understood, but several mechanisms have been proposed:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Inhibition of angiogenesis</strong>: Thalidomide has been found to inhibit angiogenesis, which is the formation of new blood vessels. This inhibition can disrupt the development of the fetus, leading to birth defects. This mechanism is widely accepted as a significant contributor to the teratogenic effects of thalidomide.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Generation of oxygen free radicals</strong>: Thalidomide may cause oxidative stress by generating oxygen free radicals, which can damage developing cells. This oxidative stress can contribute to teratogenic effects.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Binding to cereblon</strong>: Recent studies have shown that thalidomide binds to a protein called cereblon, which is involved in limb outgrowth and ear development. When thalidomide binds to cereblon, it disrupts the normal function of this protein, leading to the birth defects associated with thalidomide use.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Other mechanism includes -</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Interference with cellular signalling:</strong> Thalidomide may interfere with various cellular signalling pathways, such as those involving fibroblast growth factors, which are important for embryonic development.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Thalidomide's teratogenicity is primarily associated with mechanisms such as the inhibition of angiogenesis, generation of oxygen free radicals, and binding to the cereblon protein. It does not cause an increase in IL-2, IL-4, and IL-5; in fact, it suppresses these interleukins.</span></p>",
      "correct_choice_id": 98814,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 44841,
      "choices": [
        {
          "id": 179011,
          "text": "<p><span style=\"font-size:12pt;\">Sugammadex</span></p>"
        },
        {
          "id": 179012,
          "text": "<p><span style=\"font-size:12pt;\">Neostigmine</span></p>"
        },
        {
          "id": 179013,
          "text": "<p><span style=\"font-size:12pt;\">Edrophonium</span></p>"
        },
        {
          "id": 179014,
          "text": "<p><span style=\"font-size:12pt;\">Atropine</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">A 60-year-old male patient underwent surgery under general anaesthesia. Rocuronium was used as a muscle relaxant during the procedure. After the surgery, the patient has not regained muscle function, indicating prolonged muscle paralysis. The medical team needs to reverse the effects of rocuronium quickly to ensure patient safety and recovery. Which of the following can result in the fastest reversal? (INICET MAY 2024)</span></p>",
      "unique_key": "Q2279563",
      "question_audio": null,
      "question_video": null,
      "map_id": 32683634,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) Sugammadex</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Sugammadex is a specific reversal agent for aminosteroid neuromuscular blocking agents such as rocuronium and vecuronium. It works by encapsulating the rocuronium molecules, rendering them inactive, and thus rapidly reversing the neuromuscular blockade. Sugammadex provides the fastest and most effective reversal of rocuronium-induced paralysis.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;<strong>B.</strong>&nbsp;<strong>Neostigmine</strong>: Neostigmine is an acetylcholinesterase inhibitor that increases the levels of acetylcholine at the neuromuscular junction, competing with rocuronium. While effective, it is slower and less specific than sugammadex and can have more side effects.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;<strong>C.</strong>&nbsp;<strong>Edrophonium</strong>: Edrophonium is also an acetylcholinesterase inhibitor but is less commonly used compared to neostigmine for reversing neuromuscular blockade. It is generally faster than neostigmine but still not as rapid or effective as sugammadex for rocuronium reversal.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;<strong>D.</strong>&nbsp;<strong>Atropine</strong>: Atropine is not used for reversing neuromuscular blockade. It is an anticholinergic agent primarily used to counteract the muscarinic side effects of acetylcholinesterase inhibitors like neostigmine and edrophonium, such as bradycardia. It does not reverse muscle paralysis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">In summary, sugammadex is the most effective and fastest-acting agent for reversing the effects of rocuronium, making it the best choice in this clinical scenario.</span></p>",
      "correct_choice_id": 179011,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14418,
      "choices": [
        {
          "id": 57633,
          "text": "<p><span style=\"font-size:12.0pt;\">Thymoma</span></p>"
        },
        {
          "id": 57634,
          "text": "<p><span style=\"font-size:12.0pt;\">Neurogenic</span></p>"
        },
        {
          "id": 57635,
          "text": "<p><span style=\"font-size:12.0pt;\">Lymphoma</span></p>"
        },
        {
          "id": 57636,
          "text": "<p><span style=\"font-size:12.0pt;\">Bronchial cyst</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 42-year-old male presents to his primary care physician with chest pain and shortness of breath. Further investigation reveals a mediastinal mass on imaging studies. The patient is referred to a specialist for further evaluation. What is the most common type of tumor found in the anterior mediastinum? (AIIMS MAY 2019)</span></p>",
      "unique_key": "Q8230430",
      "question_audio": null,
      "question_video": null,
      "map_id": 32683657,
      "difficulty_level": "beginner",
      "subjects_id": [
        12
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Thymoma</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The most common anterior mediastinal tumor is thymoma, while posterior mediastinal tumor is neurogenic tumor.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The most common mediastinal tumor in children is neurogenic tumor.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Thymomas are tumors that originate from the thymus gland located in the mediastinum.</span></li><li><span style=\"font-size:12.0pt;\">They account for a significant portion of mediastinal tumors and are the most common type.</span></li><li><span style=\"font-size:12.0pt;\">Thymomas can vary in terms of malignancy, with some being benign (noncancerous) and others being malignant (cancerous).</span></li><li><span style=\"font-size:12.0pt;\">These tumors can cause chest pain, shortness of breath, and other symptoms when they grow and press on nearby structures.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Neurogenic</strong>: Neurogenic tumors, which originate from nerve tissue, are another type of mediastinal tumor found in posterior mediastinum</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Examples of neurogenic tumors include neuroblastoma and ganglioneuroma.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Lymphoma</strong>: Lymphomas can occur in the mediastinum but are less frequent than thymomas.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Lymphomas originate from lymphatic tissue and can be Hodgkin lymphoma or non-Hodgkin lymphoma.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Bronchial</strong> <strong>cyst</strong>: Bronchial cysts are fluid-filled sacs that can develop in the mediastinum but are relatively rare compared to thymomas.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In summary, thymoma is the most common type of tumor found in the mediastinum, and it originates from the thymus gland. When a patient presents with chest pain and shortness of breath and is found to have a mediastinal mass on imaging studies, thymoma is a likely consideration among other possible mediastinal tumors</span></p>",
      "correct_choice_id": 57633,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 31806,
      "choices": [
        {
          "id": 127094,
          "text": "<p><span style=\"font-size:12pt;\">Aprepitant</span></p>"
        },
        {
          "id": 127095,
          "text": "<p><span style=\"font-size:12pt;\">Dexrazoxane</span></p>"
        },
        {
          "id": 127096,
          "text": "<p><span style=\"font-size:12pt;\">Amifostine</span></p>"
        },
        {
          "id": 127097,
          "text": "<p><span style=\"font-size:12pt;\">Dexamethasone</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Which drug is used to prevent cardiotoxicity induced by daunorubicin? (INICET NOV 2023)</span></p>",
      "unique_key": "Q9019875",
      "question_audio": null,
      "question_video": null,
      "map_id": 32683646,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) Dexrazoxane</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Dexrazoxane is an iron-chelating agent used specifically to prevent cardiotoxicity associated with anthracycline chemotherapy agents like daunorubicin. It protects the heart by reducing the formation of free radicals that can damage cardiac tissue.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Aprepitant:</strong> Aprepitant is utilized to prevent nausea and vomiting caused by chemotherapy. It works as a neurokinin-1 receptor antagonist but does not have a role in preventing cardiotoxicity from chemotherapeutic drugs.</span></p><p style=\"margin-left:24px;\">&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Amifostine:</strong> Amifostine is a cytoprotective agent that offers protection against the toxic effects of chemotherapy and radiation therapy on normal tissues, particularly for kidneys and salivary glands, but it is not indicated for the prevention of cardiotoxicity from daunorubicin.</span></p><p style=\"margin-left:24px;\">&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Dexamethasone:</strong> Dexamethasone is a corticosteroid used for its anti-inflammatory and immunosuppressive effects. In oncology, it is often used to prevent chemotherapy-induced nausea and vomiting and to treat certain cancer-related conditions, but it is not used to prevent daunorubicin-induced cardiotoxicity.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Dexrazoxane is specifically used to prevent cardiotoxicity induced by anthracycline chemotherapy agents such as daunorubicin by reducing free radical formation and oxidative stress on the heart.</span></p>",
      "correct_choice_id": 127095,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 24712,
      "choices": [
        {
          "id": 98809,
          "text": "<p><span style=\"font-size:12.0pt;\">A-2, B-3, C-4, D-1</span></p>"
        },
        {
          "id": 98810,
          "text": "<p><span style=\"font-size:12.0pt;\">A-3, B-4, C-1, D-2</span></p>"
        },
        {
          "id": 98811,
          "text": "<p><span style=\"font-size:12.0pt;\">A-4, B-2, C-3, D-1</span></p>"
        },
        {
          "id": 98812,
          "text": "<p><span style=\"font-size:12.0pt;\">A-1, B-2, C-3, D-4</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Match the following drugs with the receptors they act upon:&nbsp;</span>(INICET MAY 2023)</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/02/screenshot-2023-12-02-102705.png\" alt=\"\" width=\"700\" height=\"375\"></span></p>",
      "unique_key": "Q1989528",
      "question_audio": null,
      "question_video": null,
      "map_id": 32683625,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B. A-3, B-4, C-1, D-2</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/11/whatsapp-image-2023-07-04-at-125667.jpg\" alt=\"\" width=\"900\" height=\"316\"></p><p>&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>A-3. Mirabegron&nbsp;</strong>acts on <strong>β3</strong> receptors. Mirabegron is a β3 adrenergic receptor agonist used for the treatment of bladder incontinence by relaxing the detrusor muscle during the storage phase of the urinary bladder fill-void cycle.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>B-4. Indacaterol&nbsp;</strong>acts on <strong>β2</strong> receptors. Indacaterol is a long-acting β2 adrenergic agonist used in the treatment of chronic obstructive pulmonary disease (COPD).</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>C-1. Betaxolol&nbsp;</strong>acts on <strong>β1</strong> receptors. Betaxolol is a β1 selective blocker used in the treatment of hypertension and glaucoma.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>D-2. Isoproterenol</strong> acts on <strong>β1 β2</strong> receptors. Isoproterenol is a non-selective β adrenergic agonist with no α action, used in the treatment of bradycardia and heart block.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/11/whatsapp-image-2023-07-04-at-125668.jpg\" alt=\"\" width=\"900\" height=\"243\"></p>",
      "correct_choice_id": 98810,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 24710,
      "choices": [
        {
          "id": 98801,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Matzke scale</span></span></span></p>"
        },
        {
          "id": 98802,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Salazar scale</span></span></span></p>"
        },
        {
          "id": 98803,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Rummack-mathew</span> <span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">scale</span></span></span></p>"
        },
        {
          "id": 98804,
          "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Krutzko scale</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Vancomycin nomogram is known as&nbsp;</span></span></span>(INICET MAY 2023)</p>",
      "unique_key": "Q3706398",
      "question_audio": null,
      "question_video": null,
      "map_id": 32683624,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. A. Matzke scale</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The Vancomycin nomogram is also known as the Matzke nomogram or the Matzke scale. It is a tool used to help predict the appropriate dose of vancomycin, an antibiotic, based on the patient&#39;s creatinine clearance and trough serum concentration. The nomogram is a graphical representation that allows healthcare providers to quickly and easily determine the optimal dose of vancomycin for a given patient, taking into account factors such as kidney function and the patient&#39;s weight. </span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Salazar scale</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This nomogram is not related to vancomycin dosing. It is used to predict overall survival of patients with cancer.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Rummack-Matthew scale</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This is used to assess potential hepatotoxicity after acetaminophen intake based on serum acetaminophen concentration.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Krutzko scale</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: There is no widely recognized medical scale or nomogram known as the Krutzko scale.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The Vancomycin nomogram, also known as the Matzke scale, is a crucial tool for determining the appropriate dosing of vancomycin based on creatinine clearance and trough serum concentration, ensuring both efficacy and safety in patient treatment.</span></span></span></p>",
      "correct_choice_id": 98801,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20917,
      "choices": [
        {
          "id": 83632,
          "text": "<p><span style=\"font-size:12.0pt;\">40 hours</span></p>"
        },
        {
          "id": 83633,
          "text": "<p><span style=\"font-size:12.0pt;\">80 hours</span></p>"
        },
        {
          "id": 83634,
          "text": "<p><span style=\"font-size:12.0pt;\">120 hours</span></p>"
        },
        {
          "id": 83635,
          "text": "<p><span style=\"font-size:12.0pt;\">140-180 hours</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient was given digoxin. He started having side effects like nausea and vomiting. The serum concentration of digoxin was 4 mg/dL. The plasma therapeutic range is 1 mg/dL. If the half-life of digoxin is 40 hours, how long one should wait before resuming the treatment? (NEET PG 2023)</span></p>",
      "unique_key": "Q6353504",
      "question_audio": null,
      "question_video": null,
      "map_id": 32683641,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) 80 hours</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">To determine how long it will take for the patient's serum digoxin concentration to decrease to a therapeutic level (1 mg/dL) from 4 mg/dL, we need to consider the drug's half-life. The half-life of digoxin is 40 hours, which means that every 40 hours, the concentration of the drug in the plasma will be reduced by half.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Initial concentration:</strong> 4 mg/dL</span></li><li><span style=\"font-size:12.0pt;\"><strong>Therapeutic concentration:</strong> 1 mg/dL</span></li><li><span style=\"font-size:12.0pt;\"><strong>Half-life of digoxin:</strong> 40 hours</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">We can use the concept of half-lives to calculate the time needed:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">After the first half-life (40 hours), the concentration will decrease from 4 mg/dL to 2 mg/dL.</span></li><li><span style=\"font-size:12.0pt;\">After the second half-life (another 40 hours), the concentration will decrease from 2 mg/dL to 1 mg/dL.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Therefore, it will take <strong>80 hours</strong> for the digoxin concentration to fall from 4 mg/dL to 1 mg/dL, which is within the therapeutic range.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">For a patient experiencing side effects from digoxin with a serum concentration of 4 mg/dL, wait <strong>80 hours</strong> (two half-lives) for the concentration to decrease to the therapeutic range before resuming treatment.</span></p>",
      "correct_choice_id": 83633,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 33856,
      "choices": [
        {
          "id": 135262,
          "text": "<p><span style=\"font-size:12.0pt;\">Plasma exchange</span></p>"
        },
        {
          "id": 135263,
          "text": "<p><span style=\"font-size:12.0pt;\">Cyclosporine</span></p>"
        },
        {
          "id": 135264,
          "text": "<p><span style=\"font-size:12.0pt;\">Pyridostigmine</span></p>"
        },
        {
          "id": 135265,
          "text": "<p><span style=\"font-size:12.0pt;\">Physostigmine</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A patient presented with ptosis which gets worsened by evening. He was diagnosed to be a case of myasthenia gravis. What is the preferred treatment of this patient?</span> <span style=\"font-size:12.0pt;\">(Fmge Jan 2024)</span></p>",
      "unique_key": "Q6296336",
      "question_audio": null,
      "question_video": null,
      "map_id": 32683648,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. C) Pyridostigmine</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Pyridostigmine is the preferred initial treatment for myasthenia gravis. It is effective in improving muscle strength by inhibiting the breakdown of acetylcholine, thereby increasing its availability at the neuromuscular junction. Other options like plasma exchange and cyclosporine are typically reserved for more severe cases or when standard treatments fail. Physostigmine is not commonly used for myasthenia gravis.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option A.</strong> <strong>Plasma Exchange:</strong> This is used in myasthenia gravis, particularly in cases of myasthenic crisis or before surgery. It's an acute treatment method rather than a long-term management strategy.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option B.</strong> <strong>Cyclosporine:</strong> This is an immunosuppressant used in the treatment of myasthenia gravis, usually in cases where patients do not respond to first-line treatments or as an adjunct therapy.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option D.</strong> <strong>Physostigmine:</strong> Unlike pyridostigmine, physostigmine is not commonly used for myasthenia gravis because of its central adverse effects. It is a lipid soluble cholinesterase inhibitor and is mainly used in atropine poisoning.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Pyridostigmine&nbsp;</strong>is a cholinesterase inhibitor and is the mainstay of treatment for myasthenia gravis. It helps increase the levels of acetylcholine at the neuromuscular junction, thereby improving muscle strength.</span></p>",
      "correct_choice_id": 135264,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "FMGE",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6669,
      "choices": [
        {
          "id": 26645,
          "text": "<p><span style=\"font-size:12.0pt;\">Akathisia</span></p>"
        },
        {
          "id": 26646,
          "text": "<p><span style=\"font-size:12.0pt;\">Tardive dyskinesia</span></p>"
        },
        {
          "id": 26647,
          "text": "<p><span style=\"font-size:12.0pt;\">Rabbit syndrome</span></p>"
        },
        {
          "id": 26648,
          "text": "<p><span style=\"font-size:12.0pt;\">Acute dystonia</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A young male patient has been on 5 mg haloperidol for several days. However, he has been experiencing inner restlessness and a strong want to move for the past four days. The most likely diagnosis is: (AIIMS NOV 2017)</span></p>",
      "unique_key": "Q6201600",
      "question_audio": null,
      "question_video": null,
      "map_id": 32683629,
      "difficulty_level": "beginner",
      "subjects_id": [
        16
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Akathisia</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The patient is presenting with inner restlessness and a compelling desire to be in constant motion, which is consistent with akathisia. This is a common extrapyramidal side effect of antipsychotic medications like haloperidol.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;B. Tardive dyskinesia:</strong> Tardive dyskinesia is a late-onset extrapyramidal side effect that can present as involuntary, repetitive movements of the tongue (e.g., twisting, protrusion), jaw (e.g., chewing also called.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Rabbit syndrome:&nbsp;</strong>Rabbit syndrome&nbsp;lips (e.g., smacking, puckering), trunk and extremities.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;D. Acute dystonia:</strong> Acute dystonia is the <strong>earliest side effect</strong> of antipsychotic and is characterized by sudden onset of muscle spasms, typically in the head and neck, occurring within hours to days of drug initiation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Akathisia is characterized by a <strong>sense of inner restlessness</strong> along with <strong>objective, observable movements</strong> such as fidgeting of legs, pacing around, inability to sit or stand in one place for a long time. They can present soon after starting the antipsychotic or after dosage adjustments. It is the <strong>most common extrapyramidal side effect</strong> of antipsychotics. <strong>Drug of choice is Propranolol</strong> (beta blockers).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Reference: The Maudsley Prescribing Guidelines in Psychiatry, 14th edition, Page No 114</strong></span></p>",
      "correct_choice_id": 26645,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 45442,
      "choices": [
        {
          "id": 181407,
          "text": "<p><span style=\"font-size:12.0pt;\">Cerebellopontine angle tumor</span></p>"
        },
        {
          "id": 181408,
          "text": "<p><span style=\"font-size:12.0pt;\">Maxillary Sinus Carcinoma</span></p>"
        },
        {
          "id": 181409,
          "text": "<p><span style=\"font-size:12.0pt;\">Glomus Jugulare Tumor</span></p>"
        },
        {
          "id": 181410,
          "text": "<p><span style=\"font-size:12.0pt;\">Basal Cell Carcinoma of eyelid</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Ohngren's classification and Ohngren's line are related to:(NEET PG 2017)&nbsp;</span></p>",
      "unique_key": "Q9814301",
      "question_audio": null,
      "question_video": null,
      "map_id": 32683621,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><strong>Ans. B) Maxillary Sinus Carcinoma</strong></p><p>&nbsp;</p><p><strong>Explanation:</strong></p><p>&nbsp;</p><p>Ohngren's line and classification are specifically related to <strong>maxillary sinus carcinoma</strong>. The Ohngren's line is an imaginary line drawn from the medial canthus of the eye to the angle of the mandible, dividing the maxillary sinus into antero-inferior and postero-superior halves. This classification helps determine prognosis of maxillary sinus tumors - those occurring in the postero-superior portion have worse prognosis than those in the antero-inferior portion. This classification system is important for surgical planning and prognostication in maxillary sinus malignancies.</p><p>&nbsp;</p><p><strong>&nbsp;Other Options:</strong></p><p>&nbsp;</p><p><strong>Option A. Cerebellopontine angle tumor</strong>: These tumors are classified using the Koos grading system based on size and compression of brainstem. Ohngren's classification is not used for these posterior fossa tumors.</p><p>&nbsp;</p><p><strong>Option C. Glomus Jugulare Tumor</strong>: These paragangliomas are classified using the Glasscock-Jackson classification or the Fisch classification systems, which are based on tumor extent and invasion. Ohngren's classification has no role in these tumors.</p><p>&nbsp;</p><p><strong>Option D. Basal Cell Carcinoma of eyelid</strong>: These skin malignancies are classified using TNM staging or histological patterns (nodular, superficial, morpheaform, etc.). Ohngren's line and classification are specifically for maxillary sinus tumors, not skin malignancies.</p><p>&nbsp;</p><p><strong>Educational Objective:</strong></p><p>&nbsp;</p><p>Ohngren's line divides the maxillary sinus into prognostically significant regions, with tumors posterior-superior to this line having worse prognosis due to proximity to vital structures like orbit, skull base, and pterygomaxillary fossa.</p>",
      "correct_choice_id": 181408,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6515,
      "choices": [
        {
          "id": 26029,
          "text": "<p><span style=\"font-size:12.0pt;\">Analog of UMP</span></p>"
        },
        {
          "id": 26030,
          "text": "<p><span style=\"font-size:12.0pt;\">Competitive inhibitor of DHFR</span></p>"
        },
        {
          "id": 26031,
          "text": "<p><span style=\"font-size:12.0pt;\">Blocks purine synthesis</span></p>"
        },
        {
          "id": 26032,
          "text": "<p><span style=\"font-size:12.0pt;\">Blocks pyrimidine synthesis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 16-year-old male patient is diagnosed with osteosarcoma and is scheduled to undergo chemotherapy as part of his treatment. Methotrexate is included in his chemotherapy regimen. What is the mechanism of action of methotrexate in the treatment of his osteosarcoma? (NEET PG 2021)</span></p>",
      "unique_key": "Q5781822",
      "question_audio": null,
      "question_video": null,
      "map_id": 32683670,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Competitive inhibitor of DHFR.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Methotrexate has different mechanisms for anticancer activity and for Rheumatoid Arthritis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Mechanism in Osteosarcoma (As anticancer drug):</strong> Methotrexate acts as a competitive inhibitor of the enzyme dihydrofolate reductase (DHFR). By inhibiting DHFR, methotrexate interferes with the conversion of dihydrofolate to tetrahydrofolate, an essential cofactor for DNA synthesis. This leads to a decrease in DNA and RNA synthesis, thereby arresting the cell cycle and inhibiting the growth of rapidly dividing cells, such as cancer cells in osteosarcoma.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Mechanism in Rheumatoid Arthritis (RA):</strong> Methotrexate is used at much lower doses in Rheumatoid Arthritis. In this condition, the major mechanism involves the inhibition of an enzyme called AICAR transformylase, part of the purine synthesis pathway. When AICAR transformylase is inhibited, levels of AICAR (5-aminoimidazole-4-carboxamide ribonucleotide) accumulate in the cell. This leads to an inhibition of another enzyme called adenosine deaminase, which is responsible for the degradation of adenosine. As a result, adenosine levels increase within the cell and in the extracellular environment.</span><span style=\"font-size:10.5pt;\"> </span><span style=\"font-size:12.0pt;\">Adenosine is known to have anti-inflammatory properties. When adenosine interacts with its receptors, it can lead to various effects such as inhibition of inflammatory cell function, vasodilation, and reduced pro-inflammatory cytokine release. These actions contribute to the anti-inflammatory effects observed when methotrexate is used for treating RA.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Analog of UMP</strong>: Methotrexate is not an analog of UMP (uridine monophosphate). It does not exert its effects through this mechanism.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Blocks purine synthesis</strong>: Methotrexate does not specifically block purine synthesis, although the inhibition of DHFR indirectly affects purine and pyrimidine synthesis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Blocks pyrimidine synthesis</strong>: Similar to Option C, methotrexate does not specifically block pyrimidine synthesis but indirectly affects it through DHFR inhibition.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Methotrexate's primary mechanism of action in treating osteosarcoma is as a competitive inhibitor of dihydrofolate reductase (DHFR), which interferes with DNA synthesis and cell division in rapidly dividing cells.</span></p>",
      "correct_choice_id": 26030,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 51448,
      "choices": [
        {
          "id": 205313,
          "text": "<p style=\"margin-left:-6px; text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cyclophosphamide</span></span></p>"
        },
        {
          "id": 205314,
          "text": "<p style=\"margin-left:-6px; text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bleomycin</span></span></p>"
        },
        {
          "id": 205315,
          "text": "<p style=\"margin-left:-6px; text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Paclitaxel</span></span></p>"
        },
        {
          "id": 205316,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Capecitabine</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Anticancer drug that can result in hand and foot syndrome is: (FMGE JULY 2024)</span></span></span></p>",
      "unique_key": "Q1015113",
      "question_audio": null,
      "question_video": null,
      "map_id": 32683674,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. D) Capecitabine</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Capecitabine is an oral prodrug of 5-fluorouracil (5-FU),</span></strong><span style=\"font-size:12.0pt\"> and both of these drugs are known to cause hand-foot syndrome (palmar-plantar erythrodysesthesia). This condition is characterized by redness, swelling, and pain on the palms of the hands and the soles of the feet. It occurs due to the leakage of the drug from capillaries in these areas, leading to skin toxicity. Hand-foot syndrome is a well-documented adverse effect of capecitabine, making it the correct answer in this scenario.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Cyclophosphamide:</span></strong><span style=\"font-size:12.0pt\"> Cyclophosphamide is associated with a different side effect profile, most notably hemorrhagic cystitis, which can be prevented by the administration of mesna.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Bleomycin:</span></strong><span style=\"font-size:12.0pt\"> Bleomycin is known to cause pulmonary fibrosis and can also result in flagellated pigmentation of the skin.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Paclitaxel:</span></strong><span style=\"font-size:12.0pt\"> Paclitaxel is an anticancer drug that primarily causes peripheral neuropathy.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Capecitabine &amp; 5FU can cause hand-foot syndrome, which is an important side effect to monitor in patients receiving this treatment.</span></span></p>",
      "correct_choice_id": 205316,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6531,
      "choices": [
        {
          "id": 26093,
          "text": "<p><span style=\"font-size:12.0pt;\">Vitamin B6</span></p>"
        },
        {
          "id": 26094,
          "text": "<p><span style=\"font-size:12.0pt;\">Vitamin B12</span></p>"
        },
        {
          "id": 26095,
          "text": "<p><span style=\"font-size:12.0pt;\">Vitamin B2</span></p>"
        },
        {
          "id": 26096,
          "text": "<p><span style=\"font-size:12.0pt;\">Vitamin B3</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A tuberculosis patient receiving anti-tubercular treatment complains of tingling and paresthesia in the lower limbs. He is not diabetic and drinks alcohol on occasion. Which of the following vitamins should be given to this patient?</span><span style=\"font-size:10.5pt;\"> </span><span style=\"font-size:12.0pt;\">(NEET PG 2022)</span></p>",
      "unique_key": "Q8969848",
      "question_audio": null,
      "question_video": null,
      "map_id": 32683622,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Vitamin B6</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The patient's symptoms of tingling and paresthesia in the lower limbs, in the context of receiving anti-tubercular treatment, are suggestive of peripheral neuropathy. One of the mainstays of tuberculosis (TB) treatment includes the drug isoniazid, which is known to cause vitamin B6 (pyridoxine) deficiency. Supplementing with vitamin B6 can prevent or alleviate these symptoms.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Vitamin B12</strong>: While vitamin B12 deficiency can cause peripheral neuropathy, it is not typically associated with anti-tubercular therapy. Vitamin B12 deficiency is more commonly linked to conditions like pernicious anemia or dietary deficiencies.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Vitamin B2 (Riboflavin):</strong> Deficiency of vitamin B2 can lead to various symptoms, including skin disorders and anemia, but it is not specifically linked to the type of neuropathy seen in patients taking isoniazid for TB.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Vitamin B3 (Niacin):</strong> Deficiency of vitamin B3 leads to pellagra, characterized by dermatitis, diarrhea, and dementia, and is not associated with the peripheral neuropathy observed in patients on isoniazid therapy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Patients receiving isoniazid as part of anti-tubercular therapy should be supplemented with vitamin B6 (pyridoxine) to prevent or treat peripheral neuropathy, a common side effect of this medication.</span></p>",
      "correct_choice_id": 26093,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7086,
      "choices": [
        {
          "id": 28312,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Nivolumab</span></span></span></p>"
        },
        {
          "id": 28313,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Pembrolizumab</span></span></span></p>"
        },
        {
          "id": 28314,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Atezolimumab</span></span></span></p>"
        },
        {
          "id": 28315,
          "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Cetuximab</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is not an immune checkpoint inhibitor?&nbsp;</span></span>(INICET MAY 2022)</p>",
      "unique_key": "Q1571094",
      "question_audio": null,
      "question_video": null,
      "map_id": 32683636,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. D. Cetuximab&nbsp; </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Cetuximab is a monoclonal antibody against EGFR (Epidermal Growth Factor Receptor). It is used in the treatment of Colorectal and Head and Neck Cancers. It is not an immune check point inhibitor.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A.</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Nivolumab is an immune checkpoint inhibitor. It acts by inhibiting programmed death receptor - 1 (PD-1) and are used for the treatment of advanced melanoma and classical Hodgkin lymphoma.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B.</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Pembrolizumab is an immune checkpoint inhibitor. It acts by inhibiting programmed death receptor</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">- 1 (PD-1) and are used for the treatment of advanced melanoma.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C.</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Atezolimumab is an immune checkpoint inhibitor. It acts by inhibiting programmed death-ligand - 1 (PDL-1) and is used for the treatment of urothelial, breast and non-small cell lung cancers.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Important immune check point inhibitors include:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">N</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">ew: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>N</strong>ivolumab</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">D</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">rugs: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>D</strong>urvalumab</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">ct: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>A</strong>velumab</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">At</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>At</strong>ezolizumab</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">I</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">mmune: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>I</strong>pilimumab</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">C</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">heck: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>C</strong>emiplimab</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">P</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">oint: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>P</strong>embrolizumab</span></span></span></p>",
      "correct_choice_id": 28315,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 57290,
      "choices": [
        {
          "id": 228537,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Methimazole</span></span></p>"
        },
        {
          "id": 228538,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Carbimazole</span></span></p>"
        },
        {
          "id": 228539,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Propylthiouracil</span></span></p>"
        },
        {
          "id": 228540,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Radioactive iodine</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A woman at 8 weeks of gestation is diagnosed with hyperthyroidism. Which of the following is the most appropriate treatment option? (NEET PG 2024)</span></span></span></p>",
      "unique_key": "Q2055917",
      "question_audio": null,
      "question_video": null,
      "map_id": 32683653,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Propylthiouracil</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">During the first trimester of pregnancy, Propylthiouracil (PTU) is the preferred treatment for hyperthyroidism. This preference is due to the fact that PTU has a lower risk of causing birth defects compared to Methimazole, which is associated with a rare but serious condition called aplasia cutis (a congenital skin defect). PTU is considered safer in early pregnancy, especially during organogenesis (the first trimester), as it crosses the placenta less readily than Methimazole.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Methimazole:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Methimazole is typically avoided during the first trimester because it is associated with teratogenic effects, particularly the risk of aplasia cutis and other congenital abnormalities.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Carbimazole:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Carbimazole is a prodrug that is converted to Methimazole in the body. Like Methimazole, it is also avoided during the first trimester due to the risk of congenital defects.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Radioactive iodine:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Radioactive iodine is contraindicated in pregnancy at any stage, as it can destroy fetal thyroid tissue, leading to permanent hypothyroidism in the fetus.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In the first trimester of pregnancy, Propylthiouracil (PTU) is the preferred treatment for hyperthyroidism due to its lower risk of causing birth defects compared to other antithyroid medications.</span></span></span></p>",
      "correct_choice_id": 228539,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10486,
      "choices": [
        {
          "id": 41910,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">B</span></span></span></p>"
        },
        {
          "id": 41911,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A</span></span></span></p>"
        },
        {
          "id": 41912,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">D</span></span></span></p>"
        },
        {
          "id": 41913,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">C</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Given below is an electron microscopic image of the lung tissue. A patient infected with SARS-COV2 presents with ARDS. The infection would affect and expand which of the labelled layers? (AIIMS NOV 2021)</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/14/untitled-381.jpg\" style=\"height:221px; width:400px\" /></span></span></span></p>",
      "unique_key": "Q4332800",
      "question_audio": null,
      "question_video": null,
      "map_id": 32683672,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12pt\"><strong>Ans.</strong>&nbsp;</span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>B) A </strong>&nbsp;</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The image given in the question demonstrates the electron microscopic image of the blood-air barrier in the lungs. Acute respiratory distress syndrome (ARDS) has been set in this patient with COVID-19.<strong> Damage to the endothelial (Labelled as A, with inflammation, is the key initiating event and the basis of lung damage</strong>. Neutrophils play a significant role in tissue injury in this condition.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/14/untitled-382_TF621GV.jpg\" style=\"height:253px; width:500px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/14/untitled-383.jpg\" style=\"height:222px; width:500px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The electron micrograph shows at high magnification three components of the air-blood barrier in the alveolar septum. Gaseous exchange occurs across, 1) the cytoplasm of a type I alveolar cell or pneumocyte, P1; 2) the fused basal laminas (basement membranes) of type I alveolar and endothelial cells, BM; and 3) the cytoplasm of an endothelial cell, E, enclosing a blood capillary. Note the erythrocyte, Er, present within the lumen of the blood capillary. A fourth component of the air-blood barrier, surfactant, is not preserved in routine histological sections.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/14/untitled-384.jpg\" style=\"height:242px; width:438px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">B. Basement Membrane:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> While the basement membrane is part of the blood-air barrier, it is not the primary site of injury in ARDS.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">. Type I Alveolar cell/Pneumocyte:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Although these cells are affected in ARDS, the endothelial cells are typically the first to be damaged.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">D. Erythrocyte:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> The erythrocyte is not structurally affected by ARDS but rather suffers the consequences of impaired gas exchange due to endothelial and alveolar damage.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">In ARDS, especially in cases associated with <strong>SARS-CoV-2 infection</strong>, the primary injury occurs in the <strong>endothelial cells</strong> of the blood-air barrier, leading to inflammation, increased permeability, and subsequent respiratory failure.</span></span></span></p>",
      "correct_choice_id": 41911,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 33851,
      "choices": [
        {
          "id": 135242,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Organophosphate poisoning</span></p>"
        },
        {
          "id": 135243,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Morphine poisoning</span></p>"
        },
        {
          "id": 135244,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Belladona poisoning</span></p>"
        },
        {
          "id": 135245,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Amanita phalloides toxicity</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Which of the following can result in acute liver failure? (Fmge Jan 2024)</span></p>",
      "unique_key": "Q6494080",
      "question_audio": null,
      "question_video": null,
      "map_id": 32683644,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. D) Amanita phalloides toxicity</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Among the given options, Amanita phalloides is the most direct and significant cause of liver damage. The toxins in this mushroom specifically target the liver and can lead to acute liver failure.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Amanita phalloides is a type of mushroom, commonly known as the death cap. It contains amatoxins, which are extremely toxic and can cause severe liver damage and failure. Amanita phalloides poisoning is a well-known cause of acute liver failure and is often cited in toxicology as a classic cause of this condition.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option A. Organophosphate:</strong> These are chemicals commonly found in pesticides. They are known more for their neurotoxic effects due to inhibition of acetylcholinesterase. They can cause symptoms like pinpoint pupil, increase in secretions, diarrhea, urination and muscle weakness etc. Liver damage is not the primary concern with organophosphate poisoning.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option B. Morphine:</strong> This is an opioid analgesic. Its main effects and side effects are on the central nervous system and gastrointestinal system. It can cause respiratory depression, constipation, and dependence, but it is not primarily known for causing liver damage.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option C. Belladonna:</strong> Also known as deadly nightshade, contains atropine and scopolamine. These substances can cause anticholinergic syndrome, but they are not typically associated with liver damage.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Amanita phalloides (death cap mushroom) is a well-known cause of acute liver failure due to its potent hepatotoxic amatoxins, making it a critical toxicological emergency.</span></p>",
      "correct_choice_id": 135245,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13955,
      "choices": [
        {
          "id": 55781,
          "text": "<p><span style=\"font-size:12.0pt;\">CVP (central venous pressure)</span></p>"
        },
        {
          "id": 55782,
          "text": "<p><span style=\"font-size:12.0pt;\">Urine Output</span></p>"
        },
        {
          "id": 55783,
          "text": "<p><span style=\"font-size:12.0pt;\">Blood pressure</span></p>"
        },
        {
          "id": 55784,
          "text": "<p><span style=\"font-size:12.0pt;\">Oxygen saturation</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which parameter is best used to monitor the adequacy of and guide fluid resuscitation in a patient? (AIIMS MAY 2017)</span></p>",
      "unique_key": "Q2708096",
      "question_audio": null,
      "question_video": null,
      "map_id": 32683623,
      "difficulty_level": "beginner",
      "subjects_id": [
        12
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Urine Output</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Urine output is the best measure of organ perfusion and the best monitor for adequacy of fluid resuscitation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Adequate end-organ perfusion is best indicated by urine output of &gt;0.5 to 1 mL/kg/h. However, it does not give minute-to-minute values.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. CVP (central venous pressure)</strong>: CVP is a poor reflector of preload. Central venous pressure (CVP) is the mean pressure in the superior vena cava, indicating right ventricular end-diastolic pressure or preload. Normal CVP ranges from 2 to 7 mm Hg (3 to 9 cm H20). A sick or injured patient with a CVP &lt;3 mm Hg is presumed to be volume depleted and maybe given fluids with relative safety. However, CVP is unreliable for assessment of volume status or left ventricular function.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Blood pressure</strong>: Blood pressure is an important vital sign, but it alone may not provide a complete picture of a patient's fluid status. Hypotension (low blood pressure) can be a late sign of inadequate fluid resuscitation, and normotension (normal blood pressure) does not guarantee adequate tissue perfusion. The level of consciousness is an important marker for cerebral perfusion.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Oxygen saturation</strong>: Oxygen saturation (SpO2) measures the amount of oxygen in the blood, and while it is essential for assessing respiratory status, it is not a direct indicator of fluid balance or adequacy of fluid resuscitation</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Urine output is a valuable and non-invasive parameter for assessing fluid resuscitation. Adequate urine output indicates that the patient's kidneys are functioning well and that they are likely receiving an appropriate amount of fluids. It is a practical and real-time measure of the patient's response to fluid therapy.</span></p>",
      "correct_choice_id": 55782,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "InvestigationBased",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20911,
      "choices": [
        {
          "id": 83608,
          "text": "<p><span style=\"font-size:12.0pt;\">Amiodarone</span></p>"
        },
        {
          "id": 83609,
          "text": "<p><span style=\"font-size:12.0pt;\">Atenolol</span></p>"
        },
        {
          "id": 83610,
          "text": "<p><span style=\"font-size:12.0pt;\">Aspirin</span></p>"
        },
        {
          "id": 83611,
          "text": "<p><span style=\"font-size:12.0pt;\">Spironolactone</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient with a previous history of myocardial infarction and ventricular arrhythmia is on treatment for the same since a few months. He developed fatigue, dyspnea, and weight gain. He had also developed pulmonary fibrosis. Which of the following drugs is responsible for the above-mentioned side effects? (NEET PG 2023)</span></p>",
      "unique_key": "Q2503005",
      "question_audio": null,
      "question_video": null,
      "map_id": 32683637,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Amiodarone</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The drug that is responsible for the above-mentioned side effects is amiodarone.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Amiodarone</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">→ Longest acting [t1/2 → &gt; 3 weeks] anti-arrhythmic drug</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">→ MOA →</span></p><ol><li><span style=\"font-size:12.0pt;\">Na+ channel Blocker</span></li><li><span style=\"font-size:12.0pt;\">β-Blocker (Non-competitive)</span></li><li><span style=\"font-size:12.0pt;\">K+ channel Blocker [Main action]</span></li><li><span style=\"font-size:12.0pt;\">Calcium channel blocker</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">→ Indicated in all arrhythmias except Torsades de pointes</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">→ Adverse effect of amiodarone:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/07/10/picture6.jpg\" alt=\"\" width=\"1000\" height=\"292\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Atenolol</strong>: Atenolol is a Selective Beta 1 Blocker. C/I in Bradycardia, AV Block and Acute CHF. It is used in HTN, Classical angina, MI, Chronic CHF, Arrythmia</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Aspirin</strong>: Aspirin is only irreversible COX Inhibitor, anti-platelet drug. C/I in child with viral infection (Due to Reye’s syndrome). Can cause Hyperuricemia at therapeutic doses - avoid in gout</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Spironolactone</strong>: Spironolactone is classified under potassium-sparing diuretic. Promotes sodium diuresis but maintains the body's potassium levels. C/I in patients with hyperkalemia. Can cause gynecomastia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Amiodarone&nbsp;</strong>is associated with a range of serious side effects, including pulmonary fibrosis, thyroid dysfunction, liver toxicity, and photosensitivity.</span></p>",
      "correct_choice_id": 83608,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6514,
      "choices": [
        {
          "id": 26025,
          "text": "<p><span style=\"font-size:12.0pt;\">Potassium chloride</span></p>"
        },
        {
          "id": 26026,
          "text": "<p><span style=\"font-size:12.0pt;\">Clarithromycin</span></p>"
        },
        {
          "id": 26027,
          "text": "<p><span style=\"font-size:12.0pt;\">Atenolol</span></p>"
        },
        {
          "id": 26028,
          "text": "<p><span style=\"font-size:12.0pt;\">Triamterene</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 60-year-old male patient was diagnosed with atrial fibrillation with a controlled ventricular rate. The medication charts reveal that he was taking digoxin, potassium chloride, clarithromycin, atenolol, and triamterene. Suspecting the symptoms to be due to digoxin overdose, plasma levels of digoxin were ordered. It was found that his blood levels of digoxin have increased significantly. Which of his medications is most likely responsible for this increase in digoxin levels? (NEET PG 2021)</span></p>",
      "unique_key": "Q1153669",
      "question_audio": null,
      "question_video": null,
      "map_id": 32683668,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Clarithromycin.</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Clarithromycin is known to inhibit the cytochrome P450 system, which is involved in the metabolism of many drugs, including digoxin. By inhibiting the metabolism of digoxin, clarithromycin can lead to elevated levels of digoxin in the blood, increasing the risk for digoxin toxicity.</span></li><li><span style=\"font-size:12.0pt;\">Clarithromycin also acts as an inhibitor of the P-glycoprotein and can precipitate Digoxin toxicity. P glycoproteins are drug efflux pumps in the intestine that lead to a decrease in the bioavailability of drugs. Digoxin is one of the drugs that utilizes this mechanism for its metabolism. Therefore, the drugs which inhibit the Pgp can lead to the increased plasma concentration of Digoxin and lead to its toxicity.</span></li><li><span style=\"font-size:12.0pt;\">Other drugs that inhibit the Pgp include&nbsp;</span><ul><li><span style=\"font-size:12.0pt;\">Amiodarone</span></li><li><span style=\"font-size:12.0pt;\">Verapamil</span></li><li><span style=\"font-size:12.0pt;\">Diltiazem</span></li><li><span style=\"font-size:12.0pt;\">Itraconazole</span></li><li><span style=\"font-size:12.0pt;\">Propafenone</span></li><li><span style=\"font-size:12.0pt;\">Flecainide&nbsp;</span></li><li><span style=\"font-size:12.0pt;\">Quinidine.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Potassium chloride:</strong> This medication primarily affects potassium levels and has no significant interaction with digoxin metabolism.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Atenolol</strong>: Atenolol, a beta-blocker, is not known to significantly interact with digoxin metabolism.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Triamterene</strong>: This diuretic medication primarily affects sodium and potassium levels and is not known to have a significant impact on digoxin metabolism.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Clarithromycin can significantly increase plasma levels of digoxin by inhibiting its metabolism through the cytochrome P450 system and by inhibiting P-glycoprotein, leading to an increased risk of digoxin toxicity.</span></p>",
      "correct_choice_id": 26026,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7051,
      "choices": [
        {
          "id": 28172,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Chlorothiazide</span></span></span></p>"
        },
        {
          "id": 28173,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Chlorthalidone</span></span></span></p>"
        },
        {
          "id": 28174,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Metolazone</span></span></span></p>"
        },
        {
          "id": 28175,
          "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hydrochlorothiazide</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 34-year-old man with hypertension is diagnosed with stage 4 chronic kidney disease, with eGFR of &lt;30. His doctor wants to prescribe a thiazide diuretic. Which of the following can be given? (INICET MAY 2021)</span></span></p>",
      "unique_key": "Q1411292",
      "question_audio": null,
      "question_video": null,
      "map_id": 32683628,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C. Metolazone</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">In the context of a patient with stage 4 chronic kidney disease (CKD) and an estimated glomerular filtration rate (eGFR) of less than 30 mL/min, the choice of diuretic is important, as not all diuretics are effective in patients with significantly reduced kidney function. Among the thiazides, metolazone remains effective in presence of severe renal failure whereas traditional thiazides like chlorthalidone, hydrochlorothiazide and chlorthiazide are ineffective.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The reason Metolazone remains effective in patients with advanced chronic kidney disease (CKD), where traditional thiazide diuretics are less effective, lies in their pharmacokinetic properties and the way they interact with kidney function.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Site of Action and Kidney Function:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Thiazide diuretics primarily act on the distal convoluted tubule in the kidney. They inhibit the sodium-chloride symporter, leading to increased excretion of sodium and chloride, and consequently, water.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">In advanced CKD, particularly when the eGFR (estimated glomerular filtration rate) falls below 30 mL/min, the kidney function is significantly impaired. Traditional thiazides become less effective because they depend on adequate kidney function to reach their site of action and to exert their diuretic effect.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"margin-left:96px; text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Pharmacokinetics of Metolazone:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Metolazone is classified as a thiazide-like diuretic. Unlike traditional thiazides, it retains its effectiveness even in patients with reduced kidney function.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">This is because metolazone has additional actions on the proximal tubule of the kidney, where it inhibits sodium reabsorption. This proximal action is not as dependent on kidney function as the action in the distal tubule.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>Chlorothiazide</strong>: This traditional thiazide diuretic is ineffective in patients with significantly reduced kidney function (eGFR &lt;30 mL/min).</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B</span></strong><span style=\"font-size:12.0pt\">.&nbsp;<strong>Chlorthalidone</strong>: Another traditional thiazide diuretic that is not effective in advanced CKD due to its reliance on adequate kidney function to exert its diuretic effect.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Option D.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>Hydrochlorothiazide</strong>: Like other traditional thiazides, hydrochlorothiazide is ineffective in patients with severe renal impairment.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Metolazone is the preferred thiazide-like diuretic for patients with stage 4 chronic kidney disease and an eGFR of less than 30 mL/min, as it retains its effectiveness even in the presence of significantly reduced kidney function. This is due to its additional action on the proximal tubule, which is less dependent on kidney function.</span></span></span></p>",
      "correct_choice_id": 28174,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11493,
      "choices": [
        {
          "id": 45938,
          "text": "<p><span style=\"font-size:12.0pt;\">Rituximab</span></p>"
        },
        {
          "id": 45939,
          "text": "<p><span style=\"font-size:12.0pt;\">Cladribine</span></p>"
        },
        {
          "id": 45940,
          "text": "<p><span style=\"font-size:12.0pt;\">Vemurafenib</span></p>"
        },
        {
          "id": 45941,
          "text": "<p><span style=\"font-size:12.0pt;\">Interferon-alpha</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Which of the following is the drug of choice for hairy cell leukemia? (AIIMS MAY 2020)</span></p>",
      "unique_key": "Q2807257",
      "question_audio": null,
      "question_video": null,
      "map_id": 32683662,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B)&nbsp;Cladribine</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">It is a purine analogue used in the treatment of Hairy cell leukemia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Cladribine-phosphates&nbsp;<strong>interfere with DNA synthesis&nbsp;</strong>and repair through incorporation into DNA and through <strong>inhibition of enzymes involved in DNA metabolism</strong>, including DNA polymerase and ribonucleotide reductase.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A&nbsp;&amp;&nbsp;D&nbsp;</strong>are not used in Hairy cell leukemia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C</strong>. Hairy cell leukemia patients have mutation in BRAF pathway and hence, <strong>Vemurafenib (BRAF inhibitor) is used as second line agent in refractory cases</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Cladribine remains the first-line treatment for hairy cell leukemia due to its high efficacy in inducing remissions.</span></p>",
      "correct_choice_id": 45939,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6430,
      "choices": [
        {
          "id": 25689,
          "text": "<p><span style=\"font-size:12.0pt;\">Concentration of the drug is 50% ionized and 50 % non-ionized</span></p>"
        },
        {
          "id": 25690,
          "text": "<p><span style=\"font-size:12.0pt;\">Concentration of the drug is 90% ionized and 10% non-ionized</span></p>"
        },
        {
          "id": 25691,
          "text": "<p><span style=\"font-size:12.0pt;\">Concentration of the drug is 75% ionized and 25 % non-ionized</span></p>"
        },
        {
          "id": 25692,
          "text": "<p><span style=\"font-size:12.0pt;\">Concentration of the drug is 25% ionized and 75 % non-ionized</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">When the pH = pKa of a drug, which of the following statements is true?</span><span style=\"font-size:10.5pt;\"> </span><span style=\"font-size:12.0pt;\">(NEET PG 2018)</span></p>",
      "unique_key": "Q4527083",
      "question_audio": null,
      "question_video": null,
      "map_id": 32683631,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Concentration of the drug is 50% ionized and 50 % non-ionized</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">As per the Henderson Hasselbach equation:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>pH = pKa + log (Ionized form/Non-ionized form)</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">pKa of a drug is the pH at which 50% of the drug is ionized and 50% of the drug is non-ionized.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">When the pH of the environment is equal to the pKa of the drug, the drug exists in a state where 50% is ionized and 50% is non-ionized. This is a critical concept in understanding drug solubility and absorption.</span></p>",
      "correct_choice_id": 25689,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6432,
      "choices": [
        {
          "id": 25697,
          "text": "<p><span style=\"font-size:12.0pt;\">Hydrocortisone</span></p>"
        },
        {
          "id": 25698,
          "text": "<p><span style=\"font-size:12.0pt;\">Triamcinolone</span></p>"
        },
        {
          "id": 25699,
          "text": "<p><span style=\"font-size:12.0pt;\">Methylprednisolone</span></p>"
        },
        {
          "id": 25700,
          "text": "<p><span style=\"font-size:12.0pt;\">Betamethasone</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Corticosteroid indicated for the stimulation of fetal lung maturation in preterm labor is?</span> <span style=\"font-size:12.0pt;\">(NEET PG 2018)</span></p>",
      "unique_key": "Q6348653",
      "question_audio": null,
      "question_video": null,
      "map_id": 32683633,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Betamethasone</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Corticosteroids are used in pregnant females delivering premature babies in order to prevent Respiratory Distress Syndrome in the newborn due to inadequate levels of surfactants in the lungs of premature babies. Corticosteroids also reduce the chances of development of Necrotizing Enterocolitis and Intraventricular Hemorrhage in the newborn.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">For this purpose, we can use either Dexamethasone or Betamethasone.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Dose:</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">Dexamethasone 6 mg 12 hourly x 4 doses</span></li><li><span style=\"font-size:12.0pt;\">Betamethasone 12mg 24 hourly x 2 doses</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Total dose should be 24 mg in 48 hrs.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Hydrocortisone:&nbsp;</strong>Hydrocortisone is not typically used for fetal lung maturation. It is more commonly used for adrenal insufficiency and inflammatory conditions.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Triamcinolone:&nbsp;</strong>Triamcinolone is not indicated for the stimulation of fetal lung maturation. It is primarily used for its anti-inflammatory effects in various conditions.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Methylprednisolone: </strong>Methylprednisolone is also not typically used for this purpose. It is often used for its potent anti-inflammatory and immunosuppressive properties in various conditions.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Betamethasone is the corticosteroid of choice for stimulating fetal lung maturation in preterm labor, administered to reduce the risk of neonatal respiratory distress syndrome and other complications associated with preterm birth.</span></p>",
      "correct_choice_id": 25700,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6445,
      "choices": [
        {
          "id": 25749,
          "text": "<p><span style=\"font-size:12.0pt;\">Minoxidil</span></p>"
        },
        {
          "id": 25750,
          "text": "<p><span style=\"font-size:12.0pt;\">Hydralazine</span></p>"
        },
        {
          "id": 25751,
          "text": "<p><span style=\"font-size:12.0pt;\">Nimodipine</span></p>"
        },
        {
          "id": 25752,
          "text": "<p><span style=\"font-size:12.0pt;\">Nitrendipine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Isosorbide dinitrate is indicated for congestive heart failure in combination with which of the following vasodilators?</span> <span style=\"font-size:12.0pt;\">(NEET PG 2018)</span></p>",
      "unique_key": "Q2924547",
      "question_audio": null,
      "question_video": null,
      "map_id": 32683635,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Hydralazine</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Combining hydralazine and isosorbide dinitrate (ISDN) is recommended for CHF.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The mechanism of action of hydralazine, a direct vasodilator, remains unknown. Moreover, it lowers nitrate tolerance. The combination of ISDN and hydralazine has been shown to have reduced mortality in patients of CHF.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Minoxidil: </strong>Minoxidil is a potent vasodilator used primarily for severe hypertension and not typically combined with ISDN for CHF.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Nimodipine: </strong>Nimodipine is a calcium channel blocker used primarily to treat subarachnoid hemorrhage and is not indicated for CHF.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Nitrendipine: </strong>Nitrendipine is a dihydropyridine calcium channel blocker used to treat hypertension but is not commonly used in combination with ISDN for CHF.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The combination of hydralazine and isosorbide dinitrate is indicated for the treatment of congestive heart failure, as it effectively reduces both preload and afterload, improving cardiac function and reducing symptoms and mortality in CHF patients.</span></p>",
      "correct_choice_id": 25750,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6447,
      "choices": [
        {
          "id": 25757,
          "text": "<p><span style=\"font-size:12.0pt;\">Inhibits synthesis of uric acid</span></p>"
        },
        {
          "id": 25758,
          "text": "<p><span style=\"font-size:12.0pt;\">Promotes excretion of uric acid</span></p>"
        },
        {
          "id": 25759,
          "text": "<p><span style=\"font-size:12.0pt;\">Inhibits xanthine oxidase enzyme</span></p>"
        },
        {
          "id": 25760,
          "text": "<p><span style=\"font-size:12.0pt;\">Binds to tubulin and inhibits granulocyte migration</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What is the mechanism of action of colchicine?</span> <span style=\"font-size:12.0pt;\">(NEET PG 2018)</span></p>",
      "unique_key": "Q6393626",
      "question_audio": null,
      "question_video": null,
      "map_id": 32683638,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Binds to tubulin and inhibits granulocyte migration</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Colchicine is used in acute gout to control the inflammation. It acts by blocking the microtubules and thereby blocking the chemotaxis or migration of leucocytes. It leads to severe diarrhea.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Inhibits synthesis of uric acid: </strong>Drugs that inhibit the synthesis of uric acid include allopurinol and febuxostat, which inhibit the xanthine oxidase enzyme. Colchicine does not work by this mechanism.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Promotes excretion of uric acid: </strong>Uricosuric agents such as probenecid and sulfinpyrazone promote the excretion of uric acid. Colchicine does not promote the excretion of uric acid.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Inhibits xanthine oxidase enzyme: </strong>Allopurinol and febuxostat are drugs that inhibit xanthine oxidase, reducing the production of uric acid. Colchicine does not inhibit xanthine oxidase.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Colchicine treats acute gout by binding to tubulin, inhibiting the polymerization of microtubules, and preventing the migration and chemotaxis of granulocytes. This reduces the inflammatory response associated with gout attacks.</span></p>",
      "correct_choice_id": 25760,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6476,
      "choices": [
        {
          "id": 25873,
          "text": "<p><span style=\"font-size:12.0pt;\">Obidoxime</span></p>"
        },
        {
          "id": 25874,
          "text": "<p><span style=\"font-size:12.0pt;\">Edrophonium</span></p>"
        },
        {
          "id": 25875,
          "text": "<p><span style=\"font-size:12.0pt;\">Donepezil</span></p>"
        },
        {
          "id": 25876,
          "text": "<p><span style=\"font-size:12.0pt;\">Atropine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What is the drug used to differentiate myasthenia gravis from cholinergic crisis? (NEET PG 2019)</span></p>",
      "unique_key": "Q4650820",
      "question_audio": null,
      "question_video": null,
      "map_id": 32683654,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Edrophonium</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Edrophonium is a short-acting acetylcholinesterase inhibitor that is used in the Tensilon test to differentiate myasthenia gravis from a cholinergic crisis. In patients with myasthenia gravis, the symptoms will improve following administration of edrophonium. In contrast, symptoms will worsen in a cholinergic crisis, indicating that the problem is excessive acetylcholine at the neuromuscular junction.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Obidoxime</strong>: Obidoxime is primarily used to treat organophosphate poisoning and is not used to differentiate myasthenia gravis from a cholinergic crisis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Donepezil</strong>: Donepezil is a long-acting acetylcholinesterase inhibitor used to treat Alzheimer's disease and is not used to differentiate myasthenia gravis from a cholinergic crisis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Atropine</strong>: Atropine is an anticholinergic drug used to treat a variety of conditions, including poisoning by organophosphates and other substances that produce a cholinergic crisis. However, it is not used to differentiate myasthenia gravis from a cholinergic crisis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Edrophonium is the drug used to differentiate myasthenia gravis from a cholinergic crisis by temporarily increasing acetylcholine levels at the neuromuscular junction, thereby improving symptoms in myasthenia gravis and worsening them in a cholinergic crisis.</span></p>",
      "correct_choice_id": 25874,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "OlderNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6478,
      "choices": [
        {
          "id": 25881,
          "text": "<p><span style=\"font-size:12.0pt;\">Tolvaptan</span></p>"
        },
        {
          "id": 25882,
          "text": "<p><span style=\"font-size:12.0pt;\">Reducing fluid intake to &lt;500 ml per day</span></p>"
        },
        {
          "id": 25883,
          "text": "<p><span style=\"font-size:12.0pt;\">Demeclocycline</span></p>"
        },
        {
          "id": 25884,
          "text": "<p><span style=\"font-size:12.0pt;\">Fludrocortisone</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The best approach in the treatment of chronic SIADH is? (NEET PG 2019)</span></p>",
      "unique_key": "Q3492895",
      "question_audio": null,
      "question_video": null,
      "map_id": 32683656,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Tolvaptan</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The best approach in the treatment of chronic SIADH (syndrome of inappropriate antidiuretic hormone secretion) is to use tolvaptan.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Tolvaptan is a selective vasopressin V2 receptor antagonist that works by blocking the action of antidiuretic hormone (ADH) in the kidneys, leading to increased urine output and improved serum sodium levels. It is currently the preferred treatment for chronic SIADH, as it has been shown to be effective in improving symptoms and reducing the risk of complications.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Reducing fluid intake to &lt;500 ml per day</strong> is not a recommended approach to treating chronic SIADH, as it can lead to dehydration and other complications.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Demeclocycline</strong>, a tetracycline antibiotic, is another treatment option for SIADH, but it is less effective and has more side effects compared to tolvaptan.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Fludrocortisone,</strong> a mineralocorticoid hormone, is not recommended for the treatment of SIADH, as it can worsen hyponatremia (low sodium levels) and increase the risk of fluid retention.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Tolvaptan is the best approach in the treatment of chronic SIADH due to its selective antagonism of the vasopressin V2 receptor, leading to increased urine output and improved serum sodium levels. Other methods, such as severe fluid restriction and demeclocycline, are less effective or have more side effects. Fludrocortisone is not suitable for treating SIADH and can exacerbate the condition.</span></p>",
      "correct_choice_id": 25881,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6503,
      "choices": [
        {
          "id": 25981,
          "text": "<p><span style=\"font-size:12.0pt;\">Increased free water clearance</span></p>"
        },
        {
          "id": 25982,
          "text": "<p><span style=\"font-size:12.0pt;\">V2 receptor agonism</span></p>"
        },
        {
          "id": 25983,
          "text": "<p><span style=\"font-size:12.0pt;\">Increased renal cAMP levels</span></p>"
        },
        {
          "id": 25984,
          "text": "<p><span style=\"font-size:12.0pt;\">Increase in urine osmolality</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 52-year-old male with Autosomal Dominant Polycystic Kidney Disease (ADPKD) was started on tolvaptan therapy. A few weeks later, he presents with symptoms of dry mouth and increased thirst. What is the likely mechanism behind these symptoms? (NEET PG 2020)</span></p>",
      "unique_key": "Q1795222",
      "question_audio": null,
      "question_video": null,
      "map_id": 32683663,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Increased free water clearance</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Tolvaptan is a selective vasopressin V2 receptor antagonist used in the management of ADPKD. By blocking the action of vasopressin at the V2 receptor, tolvaptan inhibits water reabsorption in the renal collecting ducts, leading to increased free water clearance (aquaresis). This can result in symptoms like dry mouth and increased thirst due to increased urine output and dehydration.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. V2 receptor agonism:</strong> Tolvaptan is a V2 receptor antagonist, not an agonist. Its mechanism of action is to block the V2 receptor, thereby increasing water excretion.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Increased renal cAMP levels:</strong> Vasopressin usually acts on the V2 receptor to increase cAMP levels, which in turn promotes water reabsorption in the collecting duct. Since tolvaptan is a V2 receptor antagonist, it would be expected to decrease cAMP levels in the kidney, not increase them.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Increase in urine osmolality:</strong> Tolvaptan's action leads to increased water excretion without a significant change in solute excretion, resulting in a decrease in urine osmolality, not an increase.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Tolvaptan causes increased free water clearance by blocking V2 receptors, leading to symptoms of dehydration such as dry mouth and increased thirst. This is a direct result of its mechanism as a V2 receptor antagonist, which inhibits water reabsorption in the renal collecting ducts.</span></p>",
      "correct_choice_id": 25981,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6876,
      "choices": [
        {
          "id": 27472,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Carbamazepine</span></span></span></p>"
        },
        {
          "id": 27473,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Lamotrigine</span></span></span></p>"
        },
        {
          "id": 27474,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Lithium</span></span></span></p>"
        },
        {
          "id": 27475,
          "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Valproate</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Which is a mood stabilizer with an anti-suicidal role? (AIIMS NOV 2017)</span></span></span></p>",
      "unique_key": "Q7540439",
      "question_audio": null,
      "question_video": null,
      "map_id": 32683661,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C. Lithium</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Lithium is the only mood stabilizer that has been consistently shown to have an anti-suicidal effect in patients with bipolar disorder and major depressive disorder. Numerous studies have demonstrated that lithium reduces the risk of suicide and suicide attempts. It is considered the gold standard for mood stabilization, particularly in bipolar disorder, due to its efficacy in preventing both manic and depressive episodes.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Mechanism of Lithium:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Mood Stabilization:</span></strong><span style=\"font-size:12.0pt\"> Lithium modulates neurotransmission by affecting various neurotransmitter pathways, including serotonin and norepinephrine.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Neuroprotective Effects:</span></strong><span style=\"font-size:12.0pt\"> Lithium enhances neurogenesis and has neuroprotective effects, potentially contributing to its anti-suicidal properties.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Reduction in Aggression and Impulsivity:</span></strong><span style=\"font-size:12.0pt\"> Lithium has been shown to reduce aggression and impulsivity, which are risk factors for suicide.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Carbamazepine:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Carbamazepine is an anticonvulsant and mood stabilizer used to treat bipolar disorder, particularly in patients with rapid cycling or mixed states. However, it does not have a proven anti-suicidal effect.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Lamotrigine:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Lamotrigine is effective as a mood stabilizer, particularly in preventing depressive episodes in bipolar disorder. While it helps in mood stabilization, it does not have a specific anti-suicidal effect.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Valproate:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Valproate is another anticonvulsant and mood stabilizer used in bipolar disorder, especially effective in rapid cyclers. It does not have an established anti-suicidal role.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Lithium is unique among mood stabilizers for its anti-suicidal properties. It significantly reduces the risk of suicide and is effective in stabilizing mood in patients with bipolar disorder and major depressive disorder. </span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Valproate is the drug of choice in rapid cyclers, whereas Lamotrigine is effective as a mood stabilizer in Depression.</span></span></span></p>",
      "correct_choice_id": 27474,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7038,
      "choices": [
        {
          "id": 28120,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Oxycodone</span></span></span></p>"
        },
        {
          "id": 28121,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Clarithromycin</span></span></span></p>"
        },
        {
          "id": 28122,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Adalimumab</span></span></span></p>"
        },
        {
          "id": 28123,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Rivoraxaban</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Rosuvastatin should not be combined with which of the following drugs? (</span></span>INICET May 2020)</p>",
      "unique_key": "Q9105179",
      "question_audio": null,
      "question_video": null,
      "map_id": 32683658,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B. Clarithromycin</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Statins are metabolized by CYP3A4 enzyme, which is inhibited by clarithromycin. The plasma levels of statins may rise to high levels if used with clarithromycin, resulting in serious adverse effects like myopathy.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>A</strong>. <strong>Oxycodone: </strong>Oxycodone is an opioid analgesic used for pain management. It does not interact significantly with rosuvastatin and does not affect its metabolism.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>C.</strong> <strong>Adalimumab: </strong>Adalimumab is a monoclonal antibody used to treat autoimmune conditions. It does not interfere with the metabolism of rosuvastatin and therefore is not associated with increased risk of myopathy when used in combination.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>D.</strong> <strong>Rivoraxaban: </strong>Rivaroxaban is an anticoagulant used to prevent and treat blood clots. It does not interact with the metabolism of rosuvastatin and does not pose a risk of increased myopathy.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Drugs increasing the risk of statin induced myopathy are:</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Amiodarone</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Gemfibrozil</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">HIV protease inhibitors like saquinavir, ritonavir etc.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Clarithromycin</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Itraconazole</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 28121,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6760,
      "choices": [
        {
          "id": 27009,
          "text": "<p><span style=\"font-size:12.0pt;\">It has rapid onset of action</span></p>"
        },
        {
          "id": 27010,
          "text": "<p><span style=\"font-size:12.0pt;\">It has less depressant action on heart</span></p>"
        },
        {
          "id": 27011,
          "text": "<p><span style=\"font-size:12.0pt;\">It has long duration of action</span></p>"
        },
        {
          "id": 27012,
          "text": "<p><span style=\"font-size:12.0pt;\">It causes less release of histamine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Cis-atracurium is preferred over atracurium because? (NEET PG 2019)</span></p>",
      "unique_key": "Q6693615",
      "question_audio": null,
      "question_video": null,
      "map_id": 32683664,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) It causes less release of histamine</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Cis-atracurium is a non-depolarizing neuromuscular blocking agent preferred over atracurium for several reasons:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\"><strong>Histamine Release</strong>: Atracurium is known to cause histamine release, which can lead to hypotension and bronchospasm in susceptible individuals. Cis-atracurium, on the other hand, is a newer and more selective agent that causes less histamine release, making it safer and better tolerated.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Metabolism</strong>: Atracurium is metabolized by plasma esterases, which can lead to variability in its effects. Cis-atracurium undergoes Hoffman elimination, a process that occurs at physiological pH and temperature, leading to more predictable and consistent metabolism, independent of organ function.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Cardiovascular Effects</strong>: While both drugs have similar cardiovascular effects, the reduced histamine release with cis-atracurium minimizes the risk of hypotension and bronchospasm, which can be beneficial in patients with cardiovascular instability.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Duration of Action</strong>: Cis-atracurium has a shorter duration of action compared to atracurium, which can be advantageous for titrating doses and facilitating recovery from anesthesia.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. It has rapid onset of action: </strong>The onset of action for cis-atracurium and atracurium is similar, so this is not the primary reason for preferring cis-atracurium over atracurium.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. It has less depressant action on heart: </strong>Both drugs have similar cardiovascular effects, and the preference for cis-atracurium is not based on a difference in cardiac depression.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. It has long duration of action: </strong>Cis-atracurium does not have a significantly longer duration of action compared to atracurium. In fact, its duration of action is similar or slightly shorter, allowing for easier titration and recovery.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Cis-atracurium is preferred over atracurium because it causes less histamine release, reducing the risk of side effects such as hypotension and bronchospasm, and it undergoes Hoffman elimination, which contributes to its safer profile and predictable metabolism.</span></p>",
      "correct_choice_id": 27012,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 44782,
      "choices": [
        {
          "id": 178775,
          "text": "<p><span style=\"font-size:12pt;\">Dapsone</span></p>"
        },
        {
          "id": 178776,
          "text": "<p><span style=\"font-size:12pt;\">Ofloxacin</span></p>"
        },
        {
          "id": 178777,
          "text": "<p><span style=\"font-size:12pt;\">Rifampicin</span></p>"
        },
        {
          "id": 178778,
          "text": "<p><span style=\"font-size:12pt;\">Clofazimine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">Which of the following drugs used in treatment of leprosy can result in hyperpigmentation?</span></p>",
      "unique_key": "Q3485053",
      "question_audio": null,
      "question_video": null,
      "map_id": 32683666,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D) Clofazimine</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Clofazimine is known to cause hyperpigmentation of the skin. This drug is used in leprosy treatment for its anti-inflammatory properties and its ability to kill Mycobacterium leprae. Clofazimine can lead to a characteristic reddish-brown to black discoloration of the skin, which can be quite distressing to patients but is usually harmless.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;<strong>A.</strong>&nbsp;<strong>Dapsone</strong>: Dapsone is an antibiotic commonly used in the treatment of leprosy. While it has various side effects, hyperpigmentation is not typically associated with dapsone. Common side effects include hemolysis (especially in individuals with G6PD deficiency) and peripheral neuropathy.</span></p><p style=\"margin-left:48px;\">&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;<strong>B.</strong>&nbsp;<strong>Ofloxacin</strong>: Ofloxacin is a fluoroquinolone antibiotic that can be used as part of alternative regimens for leprosy. Hyperpigmentation is not a known side effect of ofloxacin. Its common side effects include gastrointestinal disturbances and tendinitis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;<strong>C.</strong>&nbsp;<strong>Rifampicin</strong>: Rifampicin is another cornerstone drug in the treatment of leprosy. It can cause orange-red discoloration of body fluids (such as urine, sweat, and tears), but it does not typically cause hyperpigmentation of the skin.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">In this case, the patient's hyperpigmentation is most likely due to clofazimine. This side effect is well-documented and is a result of the drug accumulating in the skin.</span></p>",
      "correct_choice_id": 178778,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 44827,
      "choices": [
        {
          "id": 178955,
          "text": "<p><span style=\"font-size:12pt;\">Chancroid</span></p>"
        },
        {
          "id": 178956,
          "text": "<p><span style=\"font-size:12pt;\">Donovanosis</span></p>"
        },
        {
          "id": 178957,
          "text": "<p><span style=\"font-size:12pt;\">Syphilis</span></p>"
        },
        {
          "id": 178958,
          "text": "<p><span style=\"font-size:12pt;\">Gonorrhea</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">Drug resistance is most commonly seen with which of the following infections? (INICET MAY 2024)</span></p>",
      "unique_key": "Q7722657",
      "question_audio": null,
      "question_video": null,
      "map_id": 32683630,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D) Gonorrhea</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Gonorrhea is caused by the bacterium Neisseria gonorrhoeae. It is notorious for developing resistance to multiple classes of antibiotics, including penicillins, tetracyclines, fluoroquinolones, and most recently, some strains have shown reduced susceptibility to cephalosporins and azithromycin. Drug-resistant gonorrhea is a significant public health challenge, and the CDC recommends dual therapy with ceftriaxone and azithromycin to address this issue.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option&nbsp;A.</strong>&nbsp;<strong>Chancroid</strong>: Chancroid is caused by the bacterium Haemophilus ducreyi. While there have been cases of antibiotic resistance, it is not as prevalent or significant as in gonorrhea.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option&nbsp;B.</strong>&nbsp;<strong>Donovanosis</strong>: Donovanosis (granuloma inguinale) is caused by Klebsiella granulomatis. It is relatively rare, and drug resistance has not been a major issue in its treatment.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option&nbsp;C.</strong>&nbsp;<strong>Syphilis</strong>: Syphilis is caused by the bacterium Treponema pallidum. While there are concerns about resistance to some antibiotics, such as macrolides, penicillin remains highly effective, and resistance is not as significant a problem as in gonorrhea.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">In summary, gonorrhea is the infection most commonly associated with drug resistance, making it a critical concern in the treatment of STIs.</span></p>",
      "correct_choice_id": 178958,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 45434,
      "choices": [
        {
          "id": 181375,
          "text": "<p>SERM - Raloxifene</p>"
        },
        {
          "id": 181376,
          "text": "<p>SERD - Fulvestrant</p>"
        },
        {
          "id": 181377,
          "text": "<p>Herceptin - Trastuzumab</p>"
        },
        {
          "id": 181378,
          "text": "<p>Aromatase inhibitor - Triptorelin</p>"
        }
      ],
      "text": "<p>Which of the following pairings is incorrectly matched? (NEET PG 2017)</p>",
      "unique_key": "Q1436937",
      "question_audio": null,
      "question_video": null,
      "map_id": 32683667,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><strong>Correct Answer: &nbsp;D. Aromatase inhibitor - Triptorelin</strong></p><p>&nbsp;</p><p><strong>Explanation:</strong></p><p>&nbsp;</p><p>Triptorelin is incorrectly matched as an aromatase inhibitor. Triptorelin is actually a GnRH agonist (Gonadotropin Releasing Hormone agonist) that, when administered continuously, leads to downregulation of pituitary GnRH receptors, resulting in suppression of FSH and LH release, and consequently decreasing testosterone and estrogen levels. Triptorelin is used in prostatic carcinoma, endometriosis, precocious puberty and uterine leiomyoma.</p><p>&nbsp;</p><p><strong>Other Options:</strong></p><p>&nbsp;</p><ul><li><strong>A. SERM - Raloxifene:</strong> This is a correct match. Raloxifene is a Selective Estrogen Receptor Modulator that selectively acts as an estrogen agonist in bone and on lipid metabolism, but as an antagonist in endometrium and breast. It is used for prevention and treatment of osteoporosis and reduces the risk of breast cancer.</li><li><strong>B. SERD - Fulvestrant:</strong> This is a correct match. Fulvestrant is a Selective Estrogen Receptor Down-regulator. It inhibits ER dimerization so that ER interaction with DNA is prevented and receptor degradation is enhanced. It's used for locally advanced or metastatic ER positive breast cancer that has stopped responding to tamoxifen.</li><li><strong>C. Herceptin - Trastuzumab:</strong> This is a correct match. Herceptin is the brand name for trastuzumab, a monoclonal antibody used in the treatment of HER2-positive breast cancer.</li></ul><p>&nbsp;</p><p><strong>Educational Objective:</strong>&nbsp;</p><p>&nbsp;</p><p>Triptorelin is a GnRH agonist used in prostate cancer, endometriosis, and precocious puberty, while aromatase inhibitors (letrozole, anastrozole, exemestane) act by blocking the conversion of androgens to estrogens, making them useful in postmenopausal breast cancer.</p>",
      "correct_choice_id": 181378,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 64822,
      "choices": [
        {
          "id": 258465,
          "text": "<p><span style=\"font-size:16px;\">Artemether plus lumefantrine</span></p>"
        },
        {
          "id": 258466,
          "text": "<p><span style=\"font-size:16px;\">Chloroquine followed by primaquine</span></p>"
        },
        {
          "id": 258467,
          "text": "<p><span style=\"font-size:16px;\">Artesunate plus Sulfadoxine plus Pyrimethamine</span></p>"
        },
        {
          "id": 258468,
          "text": "<p><span style=\"font-size:16px;\">Mefloquine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\">A 28-year-old man from West Garo Hills district of Meghalaya presents to the Civil Hospital with intermittent fever, chills, and malaise. Laboratory findings confirm the diagnosis of uncomplicated P. vivax malaria. The region is known for its multidrug-resistant strains of P. falciparum and occasional mixed infections. Which of the following antimalarial regimens is considered the most appropriate first-line treatment for P. vivax malaria in this setting? (Twisted PYQ)</span></p>",
      "unique_key": "Q3436544",
      "question_audio": null,
      "question_video": null,
      "map_id": 32683642,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. B) Chloroquine followed by primaquine</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Explanation:</strong></span></p><p><br><span style=\"font-size:16px;\">For P. vivax malaria, the treatment strategy involves clearing the blood-stage parasites with <strong>chloroquine</strong> and eliminating the dormant liver hypnozoites with <strong>primaquine</strong> to prevent relapses. While the region is known for multidrug-resistant P. falciparum, chloroquine remains effective against P. vivax in most parts of India, including the North East.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option A: Artemether plus lumefantrine</strong> – This is the first-line treatment for multidrug-resistant P. falciparum malaria, not for P. vivax malaria.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option C: Artesunate plus Sulfadoxine plus Pyrimethamine</strong> – This combination is recommended for chloroquine-resistant P. falciparum malaria in most parts of India but is not used for P. vivax malaria.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D: Mefloquine</strong> – Mefloquine is sometimes used in multidrug-resistant P. falciparum cases, but it is not first-line therapy for P. vivax malaria.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:16px;\">P. vivax malaria requires a combination of blood schizonticidal treatment (e.g., chloroquine) and hypnozoitocidal therapy (e.g., primaquine) to ensure radical cure. Identifying the specific Plasmodium species and local resistance patterns is critical for choosing the appropriate antimalarial regimen.</span></p>",
      "correct_choice_id": 258466,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 64826,
      "choices": [
        {
          "id": 258481,
          "text": "<p><span style=\"font-size:16px;\">RNA-dependent RNA polymerase inhibition</span></p>"
        },
        {
          "id": 258482,
          "text": "<p><span style=\"font-size:16px;\">Reverse transcriptase inhibition</span></p>"
        },
        {
          "id": 258483,
          "text": "<p><span style=\"font-size:16px;\">Fusion inhibition</span></p>"
        },
        {
          "id": 258484,
          "text": "<p><span style=\"font-size:16px;\">Entry inhibition</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\">What is the primary mechanism of action of maraviroc, a drug used in the treatment of HIV? (Twisted PYQ)</span></p>",
      "unique_key": "Q1184042",
      "question_audio": null,
      "question_video": null,
      "map_id": 32683643,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. D) Entry inhibition</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Explanation:</strong></span></p><p><br><span style=\"font-size:16px;\">Maraviroc is an entry inhibitor that works by selectively binding to the CCR5 co-receptor on the surface of CD4+ T cells. By doing so, it prevents the HIV virus from binding to this receptor, blocking its entry into host cells. Maraviroc is specifically effective against CCR5-tropic strains of HIV.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option A. RNA-dependent RNA polymerase inhibition:</strong> This is the mechanism of drugs like remdesivir, used for RNA viruses like SARS-CoV-2.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option B. Reverse transcriptase inhibition:</strong> Reverse transcriptase inhibitors, such as tenofovir or efavirenz, block the enzyme responsible for converting viral RNA into DNA. This is not the mechanism of maraviroc.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option C. Fusion inhibition: </strong>Fusion inhibitors, like enfuvirtide, block the fusion of the HIV viral envelope with the host cell membrane. This is different from maraviroc's mechanism.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:16px;\">Maraviroc acts as an entry inhibitor by blocking the CCR5 co-receptor, preventing the HIV virus from entering host cells. It is effective only in CCR5-tropic HIV and is part of targeted therapy in HIV management. Understanding the distinct mechanisms of antiretrovirals is essential for optimizing HIV treatment.</span></p>",
      "correct_choice_id": 258484,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 64829,
      "choices": [
        {
          "id": 258493,
          "text": "<p><span style=\"font-size:16px;\">Repeat Inj. adenosine 12 mg</span></p>"
        },
        {
          "id": 258494,
          "text": "<p><span style=\"font-size:16px;\">Synchronized cardioversion</span></p>"
        },
        {
          "id": 258495,
          "text": "<p><span style=\"font-size:16px;\">Inj. amiodarone 300 mg</span></p>"
        },
        {
          "id": 258496,
          "text": "<p><span style=\"font-size:16px;\">Oral beta-blocker</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\">The ECG of a patient who presented to the ER is as shown below. The patient was already given a carotid massage and IV Adenosine, but the blood pressure is 100/70 mmHg. The patient remains symptomatic with palpitations and mild dizziness. What is the next best step in management? (Twisted PYQ)</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Picture1_vwEczp6.png\" width=\"940\" height=\"398\"></span></p>",
      "unique_key": "Q5365429",
      "question_audio": null,
      "question_video": null,
      "map_id": 32683647,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. A) Repeat Inj. adenosine 12 mg</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Explanation:</strong></span></p><p><br><span style=\"font-size:16px;\">In a hemodynamically <strong>stable</strong> patient with supraventricular tachycardia (SVT), the next step after vagal maneuvers fail is to administer <strong>IV adenosine</strong>. The initial dose is 6 mg, followed by a repeat dose of 12 mg if the rhythm does not convert. Since the patient is stable with BP of 100/70 mmHg, pharmacological intervention with adenosine is the preferred approach before considering cardioversion.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option B: Synchronized cardioversion</strong> – Synchronized cardioversion is indicated for <strong>hemodynamically unstable</strong> patients with tachyarrhythmias. This patient's BP and symptoms do not indicate instability, so cardioversion is unnecessary at this point.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option C: Inj. amiodarone 300 mg</strong> – Amiodarone is typically reserved for ventricular arrhythmias or refractory cases of atrial arrhythmias. It is not the first-line treatment for SVT.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D: Oral beta-blocker</strong> – While beta-blockers may be useful for rate control in atrial tachyarrhythmias, they are not the treatment of choice for acute SVT.</span></p><p><br><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:16px;\">In stable patients with SVT, adenosine is the drug of choice after vagal maneuvers fail. It effectively terminates most AV node-dependent tachyarrhythmias by temporarily blocking AV conduction. <strong>Synchronized cardioversion should be reserved for unstable cases with symptoms like severe hypotension, altered mental status, or chest pain.</strong></span></p>",
      "correct_choice_id": 258493,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 64831,
      "choices": [
        {
          "id": 258501,
          "text": "<p><span style=\"font-size:16px;\">Leprosy</span></p>"
        },
        {
          "id": 258502,
          "text": "<p><span style=\"font-size:16px;\">Fungal infections</span></p>"
        },
        {
          "id": 258503,
          "text": "<p><span style=\"font-size:16px;\">Immunomodulation</span></p>"
        },
        {
          "id": 258504,
          "text": "<p><span style=\"font-size:16px;\">Viral infections</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\">Dapsone acts as a folic acid synthesis inhibitor by competitively inhibiting the enzyme dihydropteroate synthase, which is essential for bacterial folic acid production. This mechanism underlies its therapeutic applications. Which of the following is not a primary therapeutic use of dapsone?</span></p>",
      "unique_key": "Q7772935",
      "question_audio": null,
      "question_video": null,
      "map_id": 32683650,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. D. Viral infections</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Dapsone is not effective against viruses because viruses do not rely on folic acid metabolism or dihydropteroate synthase for replication. Antiviral therapies typically target viral enzymes, replication mechanisms, or cellular entry processes, none of which involve dapsone's mechanism of action.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Dapsone’s mechanism of action involves the competitive inhibition of <strong>dihydropteroate synthase</strong>, which prevents the synthesis of dihydropteroic acid, a precursor in the folic acid pathway. This disruption in folic acid synthesis halts bacterial growth, explaining its use in:</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option A. Leprosy</strong>: Dapsone is widely used to treat leprosy caused by Mycobacterium leprae, leveraging its bacteriostatic effects.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option B. Fungal infections</strong>: Dapsone has applications in certain fungal infections, due to its folate pathway inhibition.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option C. Immunomodulation</strong>: Dapsone has immunomodulatory properties, making it effective in treating inflammatory skin conditions like <strong>dermatitis herpetiformis</strong>, where it reduces neutrophil-mediated damage.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Recognize that dapsone acts as a <strong>folic acid synthesis inhibitor</strong> and is primarily used for conditions like <strong>leprosy</strong>, certain <strong>fungal infections</strong>, and <strong>immunomodulation</strong>. Dapsone has no therapeutic role in treating <strong>viral infections</strong>, as these organisms do not utilize the folic acid pathway targeted by the drug.</span></p>",
      "correct_choice_id": 258504,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 64832,
      "choices": [
        {
          "id": 258505,
          "text": "<p><span style=\"font-size:16px;\">Acute glaucoma</span></p>"
        },
        {
          "id": 258506,
          "text": "<p><span style=\"font-size:16px;\">Cerebral edema</span></p>"
        },
        {
          "id": 258507,
          "text": "<p><span style=\"font-size:16px;\">Pulmonary edema</span></p>"
        },
        {
          "id": 258508,
          "text": "<p><span style=\"font-size:16px;\">Elevated intracranial pressure</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\">Intravenous mannitol is contraindicated in which of the following conditions? (Twisted PYQ)</span></p>",
      "unique_key": "Q3338655",
      "question_audio": null,
      "question_video": null,
      "map_id": 32683651,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. C) Pulmonary edema</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Explanation:</strong></span></p><p><br><span style=\"font-size:16px;\">Mannitol is an osmotic diuretic that works by increasing plasma osmolality, drawing fluid from intracellular and interstitial compartments into the vascular space. While this mechanism is beneficial in conditions like acute glaucoma, cerebral edema, and elevated intracranial pressure, it can exacerbate <strong>pulmonary edema</strong> by increasing intravascular volume and worsening fluid accumulation in the lungs.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option A. Acute glaucoma:</strong> Mannitol is frequently used to rapidly lower intraocular pressure in acute glaucoma by dehydrating the vitreous.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option B. Cerebral edema:</strong> Mannitol is commonly used to reduce cerebral edema and lower intracranial pressure.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D. Elevated intracranial pressure:</strong> Mannitol is indicated to manage elevated intracranial pressure by drawing water out of the brain tissue into the vascular compartment.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:16px;\">Mannitol is contraindicated in conditions like pulmonary edema or congestive heart failure due to its potential to increase intravascular volume and exacerbate fluid overload. Careful patient selection is critical when using osmotic diuretics.</span></p>",
      "correct_choice_id": 258507,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}